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"Vorrei tanto vedere un tramonto.. Ordinate al sole di 
tramontare..."   disse il Piccolo principe. 
Rispose il re: "Se ordinassi a un generale di volare da un fiore all'altro 
come una farfalla, o di scrivere una tragedia, o di trasformarsi in un 
uccello marino; e se il generale non eseguisse l'ordine ricevuto, chi 
avrebbe torto, lui o io?"    
"L'avreste voi", disse con fermezza il piccolo principe.    
"Esatto. Bisogna esigere da ciascuno quello che ciascuno puo' dare", 
continuo' il re.   
 "L'autorita' riposa, prima di tutto, sulla ragione….  
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Abstract 
Reactions in which organic compounds are oxygenated or hydroxylated are of great 
value for organic synthesis. The “oxyfunctionalization” of aromatic compounds is a 
modification of primary interest for the pharmaceutical and food industries allowing to 
obtain high-value-added compounds, characterized by a wide array of biological 
activities, starting from cheap and commercially available molecules. Selective 
oxyfunctionalization of organic substrates, however, can be a significant problem in 
organic synthesis, as these reactions are often carried out with strong oxidizing 
agents and occur with little chemo-, regio-, and enantio- selectivity. Thus, growing 
attention has been dedicated in the last years to the development of 
biotransformations, also known as bioconversions, which make use of the metabolic 
versatility of either purified enzymes or whole microorganisms to perform the 
oxyfunctionalization of organic substrates of industrial interest. These methodologies, 
compared with already established chemical processes, are appealing alternatives to 
obtain active aromatic compounds under mild experimental conditions and without 
employing toxic reagents. In this thesis project several aspects of this kind of 
biotransformation were analyzed; more in detail the attention was focused on: 
- The use of the bacterial multicomponent monooxygenase ToMO from 
Pseudomonas sp. OX1 for the production of novel hydroxylated antioxidants 
starting from commercially available aromatic precursors such as 2-
phenoxyethanol, 2,3-dihydrobenzofuran, 2-indanol and phtalan. The antioxidant 
potential of the hydroxylated compounds obtained in ToMO-catalyzed bioconversion 
was assessed both in vitro, by using the DPPH assay, and ex vivo on the embryonic 
rat cardiomyoblast cell line H9c2 subjected to oxidative stress induced by sodium 
arsenite. Not all compounds showed antioxidant potential in the DPPH assay; 
however, when cells where incubated with any of them, a differential protective effect 
towards the oxidative stress induced by sodium arsenite was observed. 
- The recombinant expression of ToMO in the GRAS host microorganism 
Bacillus subtilis to analyze the potential use of this bacterium for the industrial 
scale-up of ToMO-catalyzed hydroxylation of aromatic substrates of interest. 
To this purpose, ToMO gene cluster was cloned in two different shuttle vectors, a 
non-integrative plasmid indicated as pHT01, and Pr19, a vector that allows instead 
the direct integration of the recombinant gene in B.subtilis chromosomal DNA 
through single crossing-over. In this latter case, no integration was observed. When 
using a non-integrative shuttle vector, the ToMO system was efficiently expressed in 
E.coli, but RT-PCR experiments showed that almost no mRNA corresponding to the 
tou gene cluster appeared to be transcribed when the plasmid was inserted in 
B.subtilis. 
- The expression and purification of the Baeyer Villiger 3,6-diketocamphane 1,6 
monooxygenase (3,6 DKCMO) and its flavin reductase component from 
Pseudomonas putida NCIMB 10007. The optimization of the expression and the 
purification of these proteins will pave the way to the future biochemical 
characterization of this flavoenzyme and to its biotechnological use for the 
oxyfunctionalization of aromatic compounds of industrial interest. 
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Riassunto 
 
Attività enzimatiche microbiche per la biosintesi di nuovi antiossidanti fenolici 
e catecolici. 
Gli antiossidanti sono un gruppo di sostanze piuttosto eterogenee dal punto di vista 
chimico in grado di agire come radical scavengers e di proteggere cellule e tessuti 
dai danni ossidativi dei radicali liberi. Questi ultimi interagiscono con DNA, proteine e 
lipidi causando, rispettivamente, mutazioni, alterazione dell’attività enzimatica e 
riduzione della fluidità di membrana (Reactive oxygen species: metabolism, oxidative 
stress, and signal transduction. Apel K., Hirt H..  Annu. Rev. Plant. Biol. 2004; 
55:373-399). 
In questo panorama rivestono un ruolo particolarmente importante gli antiossidanti di 
origine vegetale, molecole che, seppur caratterizzate da una notevole varietà 
chimica, condividono la comune struttura polifenolica. Gli anelli aromatici ossidrilati in 
generale sono molto sensibili all’ossidazione e reagiscono velocemente con vari tipi 
di agenti ossidanti, tra cui i radicali liberi, comportandosi come donatori di elettroni 
(Transmitting biological information using oxygen: Reactive oxygen species as 
signaling molecules in cardiovascular pathophysiology. Shah M.A., Sauer H. 
Cardiovascular Research 2006; 71:191–194). Ad esempio, uno fra i più abbondanti e 
potenti antiossidanti nelle olive è l’idrossitirosolo –ovvero il 2-(3,4-diidrossifenil)-
etanolo– che contiene un anello catecolico. Il tirosolo, il 2-(4-idrossifenil)-etanolo, 
secondo composto antiossidante delle olive in ordine di abbondanza, contiene invece 
un anello fenolico. Tirosolo ed idrossitirosolo, essendo composti idrosolubili, sono 
presenti come tali nell’acqua di vegetazione delle olive e come esteri liposolubili nella 
frazione oleosa.  
Anche se una alimentazione varia e corretta può fornire un adeguato apporto di tali 
molecole in condizioni normali, la ridotta disponibilità degli antiossidanti più efficaci in 
forma pura ne impedisce attualmente l’impiego come veri e propri farmaci in quelle 
patologie che coinvolgono fenomeni ossidativi e danni da radicali liberi come 
aterosclerosi, diabete, eventi ischemici e cancro.  
Purtroppo, sia la purificazione degli agenti antiossidanti dalle fonti naturali che la loro 
sintesi chimica risulta attualmente difficoltosa.  
La purificazione degli antiossidanti dal materiale vegetale è resa infatti ardua dalla 
loro elevata reattività chimica, dalla termolabilità e dalla presenza di miscele 
complesse di composti simili e dei loro derivati esterificati, glicosilati ecc. La sintesi 
chimica permette agevolmente di convertire anelli fenolici in anelli catecolici, ma la 
prima reazione di ossidrilazione di un anello aromatico richiede condizioni di reazioni 
drastiche e non ecocompatibili. Inoltre, a causa della maggiore reattività dei prodotti 
monoossidrilati rispetto ai composti aromatici di partenza, è difficile controllare la 
reazione di ossidrilazione e ottenere un singolo prodotto. Di conseguenza le rese 
sono basse e il prodotto desiderato va comunque purificato a partire da miscele 
racemiche complesse.  
Le problematiche descritte hanno spinto diversi gruppi di ricerca a mettere a punto 
per i composti aromatici ossidrilati procedure di sintesi alternativa che sfruttano la 
versatilità e l’efficienza dell’attività catalitica degli enzimi batterici (A Comparative 
Study of the Synthesis of 3-Substituted Catechols using an Enzymatic and a 
Chemoenzymatic Method., J Advanced Synthesis & Catalysis  Berberian, et al 
2007.349 4-5 p: 727-739). Tali procedure prendono il nome di bioconversioni (o 
biotrasformazioni) e sono processi che sfruttano l’azione di catalizzatori biologici, 
enzimi e sistemi cellulari, per la sintesi di composti di interesse industriale. Tali 
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metodiche si basano sulla versatilità ed efficacia delle componenti biologiche per la 
trasformazione di molecole organiche, anche su substrati diversi da quelli 
convenzionali. Le tecniche di bioconversione, differentemente dai processi di sintesi 
chimica che utilizzano reagenti tossici e producono scorie spesso inquinanti, 
permettono di produrre composti puri ed enantiopuri, in maniera semplice ed in 
condizioni ecocompatibili (Monooxygenases as biocatalysts: Classification, 
mechanistic aspects and biotechnological applications Torres Pazmino, D.E., et al.,. 
J Biotechnol, 2010. 146(1-2): p. 9-24). 
Nel laboratorio presso il quale è stato svolto il presente progetto di dottorato è già 
disponibile, in forma ricombinante ed espresso nel ceppo JM109 di E.coli, il 
complesso multienzimatico della toluene/o-xilene monossigenasi (ToMO) da 
Pseudomonas sp. OX1, enzima in grado di catalizzare l’aggiunta di gruppi ossidrilici 
a diversi substrati aromatici convertendoli in molecole mono- e diossidrilate. Questo 
enzima rappresenta un sistema molto versatile da utilizzare nelle biotrasformazioni; 
studi condotti finora dimostrano infatti che impiegando le metodiche della biologia 
computazionale e dell’ingegneria proteica è possibile alterare in maniera mirata sia la 
specificità di substrato che la regioselettività della ToMO allo scopo di creare 
catalizzatori ossidrilasici dotati delle proprietà desiderate (Regiospecificity of two 
multicomponent monooxygenases from Pseudomonas stutzeri OX1: molecular basis 
for catabolic adaptation of this microorganism to methylated aromatic compounds. 
Cafaro, V., et al.,Appl Environ Microbiol, 2005. 71(8): p. 4736-43). 
Diversi mutanti dell’enzima ToMO sono stati recentemente realizzati per effettuare 
con elevata efficienza la bioconversione di una molecola economica e facilmente 
reperibile quale il 2-feniletanolo in tirosolo e idrossitirosolo. Questi ultimi sono 
composti dalla comprovata efficacia nei confronti di diverse patologie cardiovascolari. 
Nel caso specifico dell’idrossitirosolo è stato ad esempio dimostrato in vivo ed in vitro 
che questa molecola esercita un’azione protettiva che previene l’ossidazione delle 
LDL, contrastando così uno dei passaggi chiave alla base dei fenomeni di 
aterosclerosi (Antioxidants in health and disease. Young IS, Woodside JV. J Clin 
Pathol. 2001;54(3):176-86.; Antioxidant relevance to human health. Wahlqvist 
MLAsia Pac J Clin Nutr. 2013;22(2):171-6.), (The antioxidative protecting role of the 
Mediterranean diet. Hadziabdić MO, Bozikov V, Pavić E, Romić Z. Coll 
Antropol. 2012;36(4):1427-34).  
Fra i mutanti della ToMO messi a punto recentemente, la variante E103G/F176T 
espressa nel ceppo di E.coli JM109 ha consentito di ottenere, a partire dal 2-
feniletanolo e in esperimenti di bioconversione condotti in batch, una resa di tirosolo 
pari a ca. il 50%. Nel terreno di coltura esausto è stata inoltre verificata la presenza 
anche di una piccola percentuale di idrossitirosolo (Tuning the specificity of the 
recombinant multicomponent toluene o-xylene monooxygenase from Pseudomonas 
sp. strain OX1 for the biosynthesis of tyrosol from 2-phenylethanol. Notomista, E., et 
al., Appl Environ Microbiol, 2011. 77(15): p. 5428-37). 
La particolare versatilità della monoossigenasi multicomponente ToMO e le strategie 
bioinformatiche sviluppate recentemente per questo sistema, basate sul docking nel 
sito attivo della struttura cristallografica della ToMO degli intermedi della reazione di 
ossidrilazione, hanno quindi incoraggiato l’utilizzo di tale sistema enzimatico per la 
conversione di nuclei aromatici che non sono substrati naturali dell’enzima allo scopo 
di sintetizzare nuovi composti ossidrilati antiossidanti per l’industria alimentare e 
farmaceutica. 
Come sottolineato precedentemente, il sistema ricombinante utilizzato attualmente 
per l’espressione dell’enzima ToMO è l’ospite batterico Gram-negativo E.coli. Ai fini 
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di uno scale-up industriale delle bioconversioni operate tramite questa 
monoossigenasi multicomponente va però ricordato che tale microorganismo non 
rappresenta un ospite eterologo ideale per l’espressione ricombinante a causa della 
presenza, nella sua membrana esterna, del lipopolisaccaride (LPS), una endotossina 
che può provocare shock anafilattico e che sicuramente pone seri problemi negli 
eventuali processi di purificazione dei prodotti di interesse ed in generale in tutte le 
fasi di downstream processing del processo biotecnologico. Una buona alternativa 
ad E.coli è Bacillus subtilis, un batterio Gram-positivo, endo-spirogeno, aerobico, 
designato come organismo GRAS (Generally Recognized As Safe) e non patogeno 
per l’uomo (Production of recombinant proteins in Bacillus subtilis. Schumann, W., 
Adv Appl Microbiol, 2007. 62: p. 137-89). B. subtilis presenta condizioni di crescita 
simili a E. coli ed è inoltre caratterizzato da un efficiente apparato di secrezione. 
Un’altra caratteristica di questo ceppo batterico è la resistenza a condizioni 
ambientali estreme attraverso il differenziamento della spora e della cellula madre 
che la produce. Va inoltre sottolineato che è ormai disponibile una vasta gamma di 
informazioni sulla fisiologia e la genetica di B.subtilis, il che facilita il futuro 
sfruttamento di tale microorganismo e l’ottimizzazione del suo utilizzo nell’ambito 
delle bioconversioni industriali (Developments in the use of Bacillus species for 
industrial production. Schallmey M, Singh A, Ward OPCan J Microbiol. 2004 
Jan;50(1):1-17). 
Le reazioni di ossidrilazione catalizzate dalle Monoossigenasi Multicomponente 
Batteriche (BMM) quali l’enzima ToMO non rappresentano sicuramente le uniche 
reazioni di “ossifunzionalizzazione” di molecole per la produzione di composti ad alto 
valore aggiunto di interesse industriale. Le reazioni di ossidazione di “Baeyer-Villiger” 
sono delle reazioni in cui i chetoni vengono convertiti nei corrispondenti esteri. 
L’inserimento di un atomo di ossigeno in una ampia varietà di chetoni ciclici ed 
alifatici per la produzione di esteri o lattoni chirali puri è di fondamentale importanza 
nella chimica organica poiché tali molecole vengono utilizzate come intermedi e/o 
precursori per la sintesi di composti importanti per la chimica fine e di composti 
farmacologicamente attivi (Investigating the coenzyme specificity of phenylacetone 
 monooxygenase from  Thermobifida fusca. Dudek HM, Torres PazmIno 
DE, Rodríguez C, de Gonzalo G, Gotor V, Fraaije MW. Appl Microbiol 
Biotechnol. 2010 Nov;88(5):1135-43). 
Nella sintesi organica tale reazione è condotta in presenza di perossiacidi, agenti 
ossidanti molto forti e tossici il cui utilizzo presuppone l’impiego di laboriosi passaggi 
di protezione e di de-protezione per evitare la formazione di prodotti secondari 
(Investigating the coenzyme specificity of phenylacetone  monooxygenase from  
Thermobifida fusca. Dudek HM, Torres PazmIno DE,, Rodríguez C, de Gonzalo 
G, Gotor V, Fraaije MW. Appl Microbiol Biotechnol. 2010 Nov;88(5):1135-43). Le 
Monoossigenasi Baeyer Villiger (BVMOs) sono flavoenzimi e rappresentano una 
ottima alternativa da utilizzare in ambito biotecnologico; tali enzimi, infatti, sono in 
grado di catalizzare l’ossigenazione di chetoni lineari, ciclici o aromatici a esteri e 
lattoni in maniera regio- ed enantioselettiva (Cloning, expression and characterization 
of a Baeyer–Villiger monooxygenase from Pseudomonas putida KT2440. Rehdorf, J., 
Kirschner, A., and Bornscheuer, U.T. Biotechnol. 2007.Lett. 29, 1393–1398;  
Functional expression, purification, and characterisation of the recombinant Baeyer–
Villiger monooxygenase MekA from Pseudomonas veronii MEK700. Völker, A., 
Kirschner, A., Bornscheuer, U.T., and Altenbuchner, J. Microbiol. Biotechnol. 2008 
77, 1251–1260). Tali enzimi rappresentano quindi, insieme alle BMM, dei 
biocatalizzatori di primaria importanza per le biotecnologie industriali. Ad oggi solo 
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pochi geni codificanti per le BVMOs sono stati clonati ed espressi e ciò ha 
rappresentato sicuramente un grosso ostacolo verso l'applicazione industriale di 
questa classe di enzimi. 
Il presente progetto di ricerca ha avuto tre obiettivi principali: 
 
- 1) Utilizzo della BMM ToMO da Ps. sp.OX1 per la biosintesi di nuovi composti 
ossidrilati antiossidanti; 
- 2) Clonaggio dell’enzima ToMO in un vettore compatibile con l’espressione 
ricombinante di tale sistema in un ospite eterologo GRAS quale B.subtilis. 
- 3) Espressione e purificazione della BMVO 3,6-diketocamphane 1,6 monooxygenase 
(3,6 DKCMO) e della sua componente flavin reduttasica da Pseudomonas putida 
NCIMB 10007. 
 
1) Utilizzo della BMM ToMO da Pseudomonas sp.OX1 per la biosintesi di nuovi 
composti ossidrilati antiossidanti. 
Nell’ambito di tale obiettivo i composti di partenza sono stati scelti per la loro 
somiglianza con i substrati naturali di ToMO ed in funzione della diversa natura del 
sostituente legato all’anello aromatico. La presenza di gruppi differenti legati agli 
anelli aromatici può influenzare aspetti quali la reattività dei derivati ossidrilati di tali 
composti nei confronti delle specie ossidanti, la loro farmacocinetica e la 
distribuzione tissutale e cellulare. 
I substrati di partenza individuati sono stati: il 2-fenossietanolo, il 2,3 
diidrobenzofurano, il 2-indanolo e lo ftalano. Tali composti sono stati utilizzati in 
esperimenti di bioconversione in batch utilizzando cellule di E.coli, ceppo JM109 
trasformate con il plasmide pGEM3Z/wt ToMO. Per tutti i substrati, eccetto il 2-
indanolo, è stata verificata la presenza di prodotti ossidrilati nel mezzo di coltura 
esausto. Nel caso del 2-indanolo, non convertito dall’enzima wt, è stato utilizzato il 
mutante E103G/F176A, precedentemente realizzato nel laboratorio in cui il presente 
progetto è stato svolto, che mostra una cavità del sito attivo più ampia rispetto 
all’enzima wt. Tutti i prodotti di ossidrilazione presenti nel terreno di coltura esausto 
sono stati purificati su HPLC, singolarmente raccolti e identificati mediante NMR e 
spettrometria di massa. La loro analisi ha evidenziato la presenza di tre derivati 
monoossidrilati nel caso del 2-fenossietanolo, di un unico derivato fenolico nel caso 
dello ftalano e di un derivato fenolico e di uno catecolico nella bioconversione 
dell’indanolo. Nel caso del 2,3 diidrobenzofurano non è stato possibile identificare in 
maniera univoca il prodotto di ossidrilazione ottenuto. I composti ossidrilati ottenuti e 
debitamente purificati sono stati utilizzati in un saggio in vitro che utilizza un catione 
radicale cromoforo stabile, come il DPPH (difenilpicrilidrazile), e che consente di 
valutare la capacità antiossidante della molecola in esame in base alla diminuzione 
di assorbanza che si osserva in seguito alla “cattura” del radicale DPPH. Prodotti 
ossidrilati quali il 2-(2’-idrossifenossi)-etanolo, il 2-(4’-idrossifenossi)-etanolo e il 5,6-
idrossi-2-indanolo hanno dimostrato in questa tipologia di saggio una efficacia 
antiossidante comparabile a quella di antiossidanti naturali quali l’idrossitirosolo ed i 
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carotenoidi. Tutti i nuovi composti ossidrilati sono stati successivamente utilizzati in 
saggi di attività antiossidante ex vivo utilizzando la linea cellulare eucariotica H9c2 
soggetta a stress ossidativo indotto da arsenito di sodio. In questo caso è stata 
innanzitutto stimata la vitalità cellulare in presenza dei nuovi composti ossidrilati 
mediante saggio MTT e valutazione dell’apoptosi. I composti utilizzati hanno 
dimostrato di non influenzare la vitalità cellulare in maniera significativa e di poter 
essere quindi utilizzati nell’analisi più specifica di protezione dal danno ossidativo 
effettuata analizzando la formazione di quelli che vengono comunemente indicati 
come granuli da “stress”. I nuovi composti ossidrilati, aggiunti alla linea cellulare 
eucariotica prima dell’induzione dello stress, hanno dimostrato un significativo effetto 
protettivo, riducendo la formazione dei granuli. 
2) Espressione ricombinante di ToMO in un microorganismo GRAS: Bacillus 
subtilis 
Una buona alternativa ad E.coli, utilizzato attualmente per l’espressione dell’enzima 
ToMO, è B. subtilis, un batterio GRAS non patogeno per l’uomo. B. subtilis mostra 
condizioni di crescita simili a E. coli e presenta un efficiente apparato di secrezione. 
Un’altra caratteristica di questo ceppo batterico è la resistenza a condizioni 
ambientali estreme attraverso il differenziamento della spora e della cellula madre 
che la produce. 
A questo scopo il cluster genico tou è stato clonato in due differenti vettori,  
A) Pr19, un plasmide che permette l'integrazione diretta del gene ricombinante in B. 
subtilis mediante singolo crossing-over. 
B) pHT01, un plasmide non integrativo IPTG-inducibile. 
Per quanto riguarda il punto A), il cluster genico tou è stato clonato all’interno del 
vettore Pr19, ottenendo un nuovo costrutto, indicato con la sigla NIC11, a partire dal 
quale è possibile ottenere l’espressione funzionale del complesso proteico 
ricombinante nell’ospite eterologo E.coli, ceppo JM109. Quando trasferito in 
B.subtilis, tale vettore non ha purtroppo consentito la corretta integrazione del cluster 
genico tou all’interno del genoma, come evidenziato da analisi PCR e da saggi di 
attività enzimatica condotti sia su cellule integre che sugli estratti cellulari dei cloni 
trasformati di B.subtilis. 
Le attività sperimentali del punto B hanno avuto come scopo l’inserimento del cluster 
genico tou nel vettore non-integrativo pHT01; il costrutto ottenuto è stato indicato 
come pDAM10. Anche in questo caso, come nel caso del plasmide NIC11, è stato 
possibile avere l’espressione funzionale del complesso multienzimatico ToMO 
all’interno dell’ospite eterologo E.coli, ceppo JM109. Il plasmide pDAM 10 è stato 
successivamente utilizzato per la trasformazione di B.subtilis; nonostante l’elevata 
efficienza di trasformazione, prove di espressione del complesso ToMO nel nuovo 
ospite non hanno dato esito positivo. Analisi di RT-PCR hanno evidenziato, in questo 
caso, che la mancata espressione di ToMO in B.subtilis è probabilmente dovuta ad 
una quasi totale mancanza del corrispondente mRNA. 
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3) Espressione e purificazione della BMVO 3,6-diketocamphane 1,6 
monooxygenase (3,6 DKCMO) e della sua componente flavin reduttasica da 
Pseudomonas putida NCIMB 10007. 
Questa parte del mio progetto di dottorato è stata svolta nei laboratori della Prof.ssa 
Jennifer Littlechild presso il centro di biocatalisi e bioscienze dell’università di  Exeter 
(UK).  
Come sottolineato precedentemente, le Monoossigenasi Baeyer-Villiger 
rappresentano una classe di enzimi di particolare interesse nell’ambito della 
biosintesi di molecole organiche funzionalizzate per le industrie farmaceutica ed 
alimentare. Le BVMOs possono essere classificate in due gruppi. Quelle 
appartenenti al gruppo I contengono FAD e utilizzano il NADPH come donatore di 
elettroni, laddove gli enzimi del gruppo II utilizzano FMN come cofattore ed il NADH 
come donatore di elettroni. La maggior parte delle BVMOs caratterizzate fino ad ora 
appartiene al gruppo I, ma sono gli enzimi del gruppo II a rivestire un particolare 
interesse per le biotecnologie industriali grazie alla loro ampia specificità di reazione. 
Il microorganismo Pseudomonas putida NCIMB 10007 è in grado di crescere 
utilizzando la canfora quale unica fonte di carbonio ed energia. Ciò avviene grazie 
alla presenza di due BMVOs, la 2,5-diketocamphane monoossigenasi (2,5-DKCMO) 
e la 3,6-diketocamphane 1,6 monoossigenasi (3,6-DKCMO). Quest’ultima è una 
BMVO di gruppo II che ha recentemente attratto un notevole interesse da parte di 
numerosi gruppi di ricerca. 
In questo contesto si è inserito il mio lavoro sperimentale i cui obiettivi sono stati:  
- Espressione, purificazione e cristallizzazione della componente ossigenasica 
della 3,6-diketocamphane 1,6 monoossigenasi (3,6 DKCMO).  
- Clonaggio, espressione e purificazione della componente flavin reduttasica  
della 3,6-diketocamphane 1,6 monoossigenasi (3,6 DKCMO). 
L’ottimizzazione delle procedure di espressione e purificazione della componente 
ossigenasica ha consentito di ottenere discreti quantitativi di proteina purificata 
utilizzata successivamente in esperimenti di cristallizzazione. I pattern di diffrazione 
raccolti, ottenuti da diversi cristalli di buona qualità, sono attualmente in analisi 
presso il laboratorio della Prof.ssa Littlechild. 
La disponibilità di entrambe le proteine purificate, che in vivo si associano a formare 
un complesso la cui dinamica strutturale non è ancora nota, consentirà di effettuare 
nell’immediato futuro studi di co-cristallizzazione che permetteranno di acquisire 
nuovi dettagli sul meccanismo enzimatico responsabile della degradazione della 
canfora in questo microorganismo. Con una visione completa e dettagliata della 
struttura, della specificità di substrato e del meccanismo catalitico, si potrà valutare in 
modo più critico il potenziale utilizzo della 3,6-diketocamphane 1,6 monoossigenasi 
per applicazioni biotecnologiche. 
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Chapter 1 - Introduction 
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1.1 Oxidative stress in biological systems 
In living organisms, aerobic metabolic processes such as respiration and 
photosynthesis entail the generation of reactive oxygen species (ROS) in specific 
organelles such as mitochondria, chloroplasts, and peroxisomes. ROS are not the 
only free radical species generated, as cell metabolism produces also reactive 
nitrogen species usually referred to as RNS.  
In cells, both ROS and RNS are unstable and highly reactive. They become stable by 
acquiring electrons from nucleic acids, lipids, proteins, carbohydrates causing a 
sequence of chain reactions that might be responsible for cellular damage and 
disease (Fig.1) (1). 
More specifically, the different sources of ROS and RNS include the mitochondrial 
respiratory chain and enzymes such as the NADPH oxidases, xanthine oxidase, 
uncoupled nitric oxide (NO) synthases, 5-lipooxygenase, and cyclooxygenases (2). 
Decades of dedicated studies have shown that an overproduction of either ROS 
and/or RNS is implicated in several pathologies such as atherosclerosis, 
cardiovascular diseases, Parkinson and Alzheimer diseases, and some types of 
cancer. 
However, ROS and RNS should not be considered as being only detrimental as they 
can specifically modulate diverse intracellular signaling pathways  and induce distinct 
changes in cell phenotype that are important in many physiological processes (2). 
Indeed, some ROS such as H2O2 are ideal as signaling molecules because they are 
small, highly diffusible, and can be rapidly generated and degraded. Moreover ROS 
and RNS have been suggested to be involved, among others, in host defense 
against invading pathogens (3). 
The three major types of ROS are superoxide (O2•
−/HO2•) anions, hydrogen peroxide 
(H2O2), and hydroxyl radical (OH•) (4). Superoxide radicals are mainly formed when 
electrons “leak” from the electron transport chain.  
Dismutation of superoxide leads to the formation of hydrogen peroxide. Hydrogen 
peroxide, although more oxidizing than superoxide, is biologically less toxic (3). 
Hydroxyl radical is highly reactive and can modify purines and pyrimidines causing 
strand breaks and thus DNA damage. OH• is nonselective and can react with a wide 
array of biological molecules. 
Nitric oxide (NO) and nitrogen dioxide are the most common RNS. NO is synthesized 
during the conversion of L-arginine to L-citrulline catalyzed by nitric oxide synthase 
(NOS). NO regulates in many tissues a diverse range of physiological processes, but 
an excess of NO can be toxic. As a matter of fact, RNS have been associated with 
asthma, septic shock and atherosclerosis (3). 
The complicated “ménage à trois” between the cell from one side and the reactive 
species of both oxygen and nitrogen on the other is maintained in a delicate 
equilibrium thanks to a complex array of non-enzymatic and enzymatic detoxification 
mechanisms whose role is to guarantee inside the cell the correct balance between 
prooxidants and antioxidant species.  
An imbalance in favor of the prooxidants is usually indicated as “oxidative stress” and 
can potentially lead to cellular damage. Evidence has been accumulating which 
shows that oxidative stress is not merely responsible for the aging process, as 
previously thought, but might represent a common element linking diverse 
mechanisms responsible for the initial onset of several diseases such as cancer, 
neurodegenerative and cardiovascular diseases, arthritis and inflammation (5-8).  
Antioxidants are compounds or enzymatic systems that reduce, neutralize and 
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prevent the damage induced in cells by free radicals (9-10). In the human body there 
are two types of antioxidants, either enzymatic or non-enzymatic. The first type 
consists of enzymes such as superoxide dismutase, catalase, glutathione peroxidase 
and glutathione reductase. Non-enzymatic antioxidants are antioxidant vitamins and 
minerals such as vitamin C, vitamin E, selenium, zinc, taurine, hypotaurine, 
glutathione, -carotene and carotene (3). It is now evident that regular consumption 
of vegetables, fruits, red wine and tea, which contain antioxidants, is associated with 
lower incidences of many chronic diseases, including cancer (11-12). Although a 
varied and healthy diet can provide an adequate intake of these molecules in normal 
conditions, the reduced availability of more effective antioxidants in pure form 
currently precludes the use of real drugs in those diseases directly depending on 
oxidation and damage caused by free radicals such as atherosclerosis, diabetes, 
ischemic events and cancer (13).  
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Figure 1: Mechanisms of oxidative stress-induced cell damage (Image from 
from Agarwal et al. Reproductive Biology and Endocrinology 2005 3:28). 
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The demand for natural and synthetic antioxidants to strengthen endogenous 
defenses has undoubtedly grown in recent years. Antioxidants must react with 
radicals and other reactive species faster than biological substrates, thus protecting 
biological targets from oxidative damage.  
However, much caution should be taken into account in the validation of antioxidants 
as pharmacological molecules. In fact, although vitamin E, ascorbate and -carotene 
are excellent antioxidants in model systems, supplements of these compounds in 
clinical trials do not seem to have generated the expected beneficial effects on 
patients. Therefore, the challenge for the future is to gain further information on the 
effective role of antioxidant molecules inside the cell to efficiently prevent and treat 
diseases related to oxidative stress. 
 
1.2 Phenols and catechols as antioxidants 
Phenols are endowed with the property of suppressing or delaying spontaneous 
autoxidation of organic molecules (14). Therefore, these compounds might be useful 
to prevent in vivo the consequences of the autoxidation of biomolecules.  
Plants have been the main suppliers of molecules analyzed as potential antioxidant 
drugs, due to their high content of phenolic compounds such as phenolic acids and 
flavonoids. Indeed, as underlined in the previous paragraph, the consumption of fruits 
and vegetables, which contain plenty of phenolic antioxidants, has been 
demonstrated to significantly reduce the risk of cancer. These properties have 
generated in the last decades a great interest in phenolic antioxidants, particularly 
after the discovery that the main lipid-soluble antioxidant present in human blood is a 
phenol, namely -tocopherol (15). Therefore, the design and production of novel 
phenolic antioxidants has recently attracted much interest in the scientific community. 
Indeed, the most popular synthetic antioxidants currently used are phenolic 
compounds such as butylated hydroxyanisole (BHA), butylated hydroxytoluene 
(BHT), tert-butylhydroquinone (TBHQ) and propyl gallate (PG) (Fig. 2), even though 
BHA and BHT have been restricted by legislative rules due to doubts of their toxic 
and carcinogenic effects (16). 
Despite all the interest towards phenolic antioxidants, there are still many details to 
unravel concerning their biological activity. The analysis of kinetic and 
thermodynamic data available so far in the literature indicates that the efficiency of 
phenols as inhibitors of the autoxidation of organic matter depends on a variety of 
factors, and this becomes particularly challenging in complex systems such as living 
organisms. The design of new phenolic antioxidants must therefore take into 
consideration most of these physical/chemical constraints. Among the possible 
mechanisms proposed to explain the antioxidant potential of phenols, one hypothesis 
might be that these molecules chelate and inactivate free metal ions that are an 
important intracellular source of free radicals.  
Phenols have other interesting biological activities of pharmacological interest, as it 
has been described for example for 4-hydroxyanisole (4-OHA). Several reports have 
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Figure 2: The most popular synthetic antioxidants. BHA, butylated 
hydroxyanisole; BHT, butylated hydroxytoluene; TBHQ, tert-
butylhydroquinone; (Image from Gülçin I. Antioxidant activity of food 
constituents: an overview Arch Toxicol (2012) 86:345-391). 
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indicated highly specific antitumor activity of 4-OHA against melanoma cells both ex 
vivo and in vivo. 
This specific antitumor activity has been proposed to be due to the oxidation of 4-
OHA by tyrosinase, an abundant enzyme found in melanocytes, to form catechol and 
then o-quinone which is highly cytotoxic (17). 
In this framework, other antioxidant pharmacophores have been identified, among 
which catechols, 1,2-dihydroxybenzenes, have been given much attention (18) as 
they are very susceptible to oxidation and react quickly with various oxidizing agents, 
including free radicals, acting as electron donors. For these molecules it is commonly 
accepted that the key factor underpinning the antioxidant effect depends on the fact 
that the semiquinone radical derived from H-atom donation of catechol can be 
stabilized by both an intramolecular hydrogen bond and the electron-donating 
properties of the ortho-OH (Fig.3) (19-21).  
The Comprehensive Medicinal Chemistry (CMC) database shows the presence of 
many drugs containing the catechol moiety for which several pharmacological effects 
have been described such as antioxidant, adrenergic, antihypertensive, 
bronchodilator, and antiparkinsonian activity (22). The diverse range of potential 
pharmacological effects as well as the need to find approaches to overcome the 
potential toxicity frequently described for these molecules (18,22) have recently 
encouraged the use of catechols as scaffolds for designing novel bioactive 
molecules. Indeed, the different nature of the substituents bound to the catechol ring 
may influence, among others, the reactivity towards oxidizing agents, the 
pharmacokinetics, the tissue and cellular distribution of these compounds (18).  
In addition to their medical applications, catechols and their substituted derivatives 
are employed in many industrial processes, such as the manufacture of photographic 
developers, inks, insecticides, rubber, plastics, and are essential precursors for the 
production of a large number of fine-chemicals, and synthetic flavor compounds (23).  
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Figure 3: H-atom abstracting reactions occurring in catechol (Image from 
Zhang H.I. Structure-activity relationships and rational design strategies for 
radical-scavenging antioxidants Curr. Comput.-Aided Drug Des. (2005) 
1:257-273). 
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1.3 Microbial biotransformations for the production of phenolic antioxidants 
Reactions in which organic compounds are oxygenated or hydroxylated are of great 
value for organic synthesis; several hydroxylated aromatic intermediates are in fact 
widely used in the industrial production of polymers and drugs (24,25). Selective 
oxyfunctionalization of organic substrates, however, can be a significant problem in 
organic synthesis, as these reactions are often carried out with strong oxidizing 
agents and occur with little chemo-, regio-, and enantio- selectivity. As a 
consequence, the synthesis of phenols and catechols by chemical methods is often 
complex, resulting in low yields and the formation of racemic mixtures (26,27). Thus, 
growing attention has been dedicated in the last years to the development of 
biotransformations, also known as bioconversions, which make use of the metabolic 
versatility of either purified enzymes or whole microorganisms to perform 
oxyfunctionalization of organic substrates of industrial interest. These methodologies, 
compared with already established chemical processes, are appealing alternatives 
for obtaining active aromatic compounds under mild experimental conditions and 
without employing toxic reagents (25). 
Purified enzymes and whole-cell biocatalysts (28) have several attractive properties 
which make them privileged catalysts for organic synthesis. In fact, they show high 
chemo-,regio- and stereoselectivity and require mild reaction conditions. Therefore, 
biocatalysis offers great chances and advantages for successful industrial 
applications, also in cases where either substrates or products of a reaction are 
chemically labile. The complex organization of specific enzymes combined with 
aspects such as cofactor dependency and low stability in isolated form, often favors 
the use of whole cells over that of isolated enzymes. Whereas whole cells generally 
offer a simple and effective option for cofactor regeneration and enhanced enzyme 
stability, protein engineering and the use of single enzymes is sometimes considered 
more economic and practical (29).  
The biocatalysis industry has currently high potential and resources (30-32) 
according to the increasing availability of sequenced genomes and the existence of a 
huge unexplored microbial diversity. In addition, it should be noted that, through 
recombinant DNA technologies, the number of enzyme variants available continues 
to increase steadily.  
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1.4 Bacterial Multicomponent Monooxygenases: ToMO as a case study 
The complications experienced in the chemical synthesis of substituted monocyclic 
aromatic compounds from more readily available precursors have boosted the 
research for alternative enzymatic or chemoenzymatic routes to phenols and 
catechols. Among others, Bacterial Multicomponent Monooxygenases (BMMs), a 
diverse group of non-heme diiron enzymes able to catalyze a variety of complex 
oxidation reactions on aromatic compounds, have several attractive properties which 
make them privileged catalysts for oxyfunctionalization reactions on aromatic 
compounds such as benzenes and phenols to produce the corresponding catechols 
(33-34,25). In recent years both directed evolution and rational design have been 
successfully used to identify the molecular determinants responsible for BMMs 
regioselectivity and to improve their activity towards natural and non-natural 
substrates. Monooxygenase biocatalysts are already used in the chemical industry to 
obtain additives for agriculture, synthones, drugs, and plastics and due to their 
catalytic properties, these multicomponent enzymes, either wild type (wt) or 
engineered, are a versatile biosynthetic tool for the preparation of different active 
aromatic compounds (25). Toluene o-xylene monooxygenase (ToMO) from 
Pseudomonas sp. OX1 (Fig.4) is a BMM that belongs to the subfamily of the four 
component aromatic/alkene monooxygenases (group 2 BMMs) (33). 
ToMO is endowed with a broad spectrum of substrate specificity and, among others, 
is able to oxidize o-, m-, and p-xylene, 2,3- and 3,4-dimethylphenol, toluene, cresols, 
benzene, naphthalene, and styrene. The ToMO multicomponent system has been 
thoroughly investigated to identify the molecular determinants responsible for its 
regioselective hydroxylation of aromatic compounds (35,36).  
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Figure 4:  
A) 3-D structure of the hydroxylase component ToMOH of the ToMO 
multicomponent system. In the ribbon diagram, subunits A, B and E are 
in green, blue and violet, respectively; iron atoms are in red.  
B) Scheme of the ToMO electron transport chain that shuttles electrons 
from NADH to oxygen through subunits F and C and the hydroxylase 
complex ToMO H with quaternary structure (BEA)2. 
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Moreover, a computational model has been recently developed that quantitatively 
predicts the effects of mutations into the active-site pocket of ToMOA (Fig.4), thus 
allowing the rational design of variants of the enzyme endowed with the desired 
regioselectivity (37). The biocatalytic potential of ToMO has been recently confirmed 
by its use for the production of tyrosol and hydroxytyrosol, strong antioxidants 
commonly found in extra virgin olive oil, starting from a low-added-value, 
commercially available aromatic precursor such as 2-phenylethanol (Fig.5) (38). 
Tyrosol and hydroxytyrosol belong to a class of natural phenolic antioxidants, 
commonly referred to as “nutraceuticals” (39-41) whose role in the prevention of 
diseases such as cancer and cardiovascular diseases is rapidly emerging (42-49). 
Hydroxytyrosol is one of the most abundant and powerful antioxidant catechol found 
in olive fruits and in extra-virgin olive oil. Tyrosol and hydroxytyrosol are compounds 
of proven efficacy against various cardiovascular diseases and of particular interest 
in food and pharmaceutical industries. In the case of hydroxytyrosol it has been 
demonstrated in vivo and in vitro that this molecule exerts a protective action that 
prevents oxidation of LDL, thus counteracting one of the key underlying phenomena 
of atherosclerosis (46-49).  
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Figure 5:  
ToMO-catalyzed conversion of A) 2-phenylethanol to tyrosol 
and B) tyrosol to hydroxytyrosol.  
B) 
A) 
2-phenylethanol 
tyrosol 
tyrosol hydroxytyrosol 
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There are many protocols for the chemical synthesis of tyrosol and hydroxytyrosol, 
which are currently mainly produced by extraction from oil mills wastewaters. 
However, either the purification of antioxidants from natural sources or their chemical 
synthesis is difficult. The former is made difficult by the high chemical reactivity of 
these molecules, the thermolability and the presence of complex mixtures of similar 
compounds and of their esterified derivatives. On the other hand, chemical synthesis 
can easily convert phenolic rings into catechol rings, but the first reaction of an 
aromatic ring hydroxylation requires harsh conditions of reaction. In addition, 
because of the increased reactivity of mono-hydroxylated products compared to the 
starting compound, it is difficult to control the hydroxylation reaction and to obtain a 
single product. Consequently, yields are low and the desired products need to be 
purified from complex mixtures. 
Due to the inability of wt ToMO to produce tyrosol as the sole isomer from the 
hydroxylation of 2-phenylethanol, a non-natural substrate of this enzyme, a 
computational model which provides a molecular explanation for this outcome was 
developed. To validate the computational model, several ToMO variants were 
designed and tested for their ability to transform 2-phenylethanol into tyrosol (38). 
More specifically, it was shown that variants E103G/F176T and E103G/F176I were 
the most efficient catalysts in the bioconversion of 2-phenylethanol to tyrosol and 
hydroxytyrosol. 
In conclusion, all the experimental data gathered so far on this enzymatic system 
concur in suggesting that ToMO is a versatile candidate for the development of 
enzymatic oxyfunctionalization processes of industrial interest using both natural and 
non-natural substrates. 
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1.5 Baeyer Villiger monooxygenases as biocatalysts 
The “Baeyer-Villiger” oxidation reaction was first discovered by Adolf von Baeyer and 
Victor Villiger more than a hundred years ago (50). In this reaction, ketones are 
converted into the corresponding esters (Fig.6). The insertion of an oxygen atom in a 
range of aliphatic and cyclic ketones to produce optically pure chiral esters or 
lactones is of fundamental importance in organic chemistry as these molecules serve 
as primary intermediates and/or precursors for the synthesis of industrially important 
fine chemicals and pharmacologically active compounds (51-54). 
In organic chemistry, peroxy acids are commonly used as catalyst to perform this 
atypical oxidation reaction that results in oxygen insertion into a carbon-carbon bond.  
However, the chemical Baeyer-Villiger reaction shows several drawbacks such as 
poor regio- and enantioselectivity, environmentally unfriendly reaction parameters 
(use of halogenated reagents and solvents) as well as the use of toxic peroxy acids 
These latter are powerful oxidative agents; therefore, laborious protection and 
deprotection steps are requested in order to prevent by-product formation. 
These drawbacks have encouraged a great deal of interest in the use of enzymes 
referred to as Baeyer Villiger monooxygenases (BVMOs) that are endowed with the 
ability to catalyze the nucleophilic oxygenation of linear, cyclic or aromatic ketones to 
esters or lactones in a region and enantio-selective manner.  
Microorganisms have been found to use BVMOs in order to grow on aliphatic methyl 
ketones (55), alicyclic hydrocarbons (56) aromatic compounds (57), and terpenes 
(58) as carbon source.  
All BVMOs characterized to date are NAD(P)H-dependent flavoproteins that use 
flavin cofactors to catalyze the insertion of an oxygen atom into ketone substrates to 
generate esters and/or lactones. These enzymes are endowed with the ability to 
catalyze regio- and enantioselective Baeyer-Villiger oxidations of a wide range of 
carbonylic compounds, as well as epoxidations, and enantioselective sulfoxidations. 
These conversions are of great biotechnological interest because they produce high-
added value intermediates and allow transformations that are otherwise difficult to 
achieve using chemical approaches, as underlined above (59). A special feature of 
these atypical monooxygenases is that they do not only catalyze Baeyer-Villiger 
oxidations but also sulfoxidations and a number of other oxidation reactions.  
BVMOs are actually considered very promising targets for biocatalytic applications in 
synthetic and pharmaceutical chemistry.  
Most importantly, BVMOs such as for example the 4-Hydroxyacetophenone 
monooxygenase from Pseudomonas fluorescens ACB, perform Baeyer-Villiger 
oxidation reactions of aromatic compounds (60). Thus, these enzymes can be 
considered, along with BMMs, another important element in the toolbox of 
biocatalysts of industrial interest capable of performing oxyfunctionalization reactions 
of aromatic substrates. 
Several different mechanisms have been proposed for the O2-driven reactions 
catalyzed by BVMOs which share a dependence of these enzymes for a reduced 
nicotinamide coenzyme such as NAD(P)H for the reduction of the FAD cofactor. This 
latter, once reduced, rapidly reacts with molecular oxygen to form a reactive 
peroxyflavin intermediate. After the oxygenation of the substrate, the enzyme reverts 
to the oxidized state; subsequently, the oxidized NAD(P)+ coenzyme is released (61). 
A key feature of BVMOs and related monooxygenases is the dual role of NADP(H) in 
catalysis. It acts in fact as the electron donor to reduce the flavin, and it is also 
required for the stabilization of the essential flavin-peroxide intermediate (62). The 
recently elucidated BVMO crystal structures, that have allowed a detailed insight into 
28 
the complex mechanism of these flavin-containing enzymes, and the recent 
identification of several novel members of this family of enzymes, have boosted the 
research efforts towards the study and engineering of these unique oxidative 
biocatalysts to understand their effective potential for future industrial applications 
(63). By using random mutagenesis and site directed evolution approaches, it has 
been highlighted the possibility to expand the substrate specificity, as well as to 
improve and change the stereoselectivity of BVMOs such as, for example, the 
cyclopentanone monooxygenase (64). Moreover, the designing of chimeric BVMOs, 
which has provided the recombinant enzymes produced with the novel selectivities of 
other BVMOs, has been also recently developed (65).  
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Figure 6: The reaction mechanism hypothesized for the Baeyer Villiger 
oxidation reaction.  
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1.6 Bacillus subtilis in industrial biotransformations 
Escherichia coli is the preferred host for the heterologous expression and production 
of recombinant proteins. This microorganism is in fact well known for its ease of 
handling, its short time of generation and its ability to accumulate high amount of 
recombinant protein in the cytosol. Nevertheless, E. coli expression systems show 
several limits such as low expression rates, formation of inclusion bodies, improper 
protein-folding and inability to produce complex disulfide bonds. This is due, among 
others, to the lack of fundamental molecular mechanisms for an efficient secretion, 
the low chaperone and foldase levels and the high concentration of periplasmic 
proteases (66). 
One of the main alternative to E.coli for the heterologous expression of recombinant 
proteins is Bacillus subtilis, a non–pathogenic, GRAS (Generally Recognized As 
Safe) microorganism.  
B. subtilis is generally free of endotoxins, and, compared with E. coli, offers high 
biosynthetic capacity and an efficient secretion apparatus that directs expressed 
proteins directly into the culture supernatant. Bacillus species are attractive industrial 
organisms for a variety of reasons, including their high growth rates that allow short 
fermentation cycle times. In addition, much information is now available on the 
biochemistry, physiology, and genetics of B. subtilis, which facilitates further 
development and a future greater exploitation of this microorganism in industrial 
processes (67).  
Furthermore, B. subtilis shows several advantages over fungal expression systems 
such as smaller process times, cultivation techniques for the production of industrial 
enzymes already standardized, and a greater variety of tools for its genetic 
manipulation (68).  
Nonetheless, several technical drawbacks have been described in the use of B. 
subtilis such as plasmid instability, and low yields of heterologous protein production, 
which currently limit the biotechnological potential of this microorganism (68). 
Plasmid instability can be overcome with the use of integration vectors, characterized 
by the presence of chromosomal regions of B. subtilis (100-200 bp), which virtually 
allow the integration of any gene in a specific site through homologous 
recombination. The integration can be mediated through a single or a double 
crossing over (Fig. 7). Low yields of recombinant protein expression are frequently 
due to the presence of proteases that cleave proteins expressed in Bacillus; this 
aspect has been overcome with the use of specific protease deficient strains (68). In 
conclusion, B. subtilis might represent an ideal host for the recombinant expression 
of enzymes used in industrial biocatalysis such as BMMs and BVMOs. However, up 
to now, there is a fundamental lack in the scientific literature concerning the use of 
this microorganism for the recombinant expression of proteins belonging to both 
these families of enzymes. 
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Figure 7: Models for single or double crossing-over strategies 
to insert a specific gene in Bacillus subtilis genome. 
32 
 
1.7 Aim of the PhD project 
Main objectives of my PhD project have been: 
1)The production of new antioxidant phenols and catechols using the catalytic 
activity of ToMO on non-natural substrates. 
The model compounds for this study were chosen on the basis of their similarity with 
the natural aromatic substrates of ToMO (Fig.8): 
- 2-phenoxyethanol, a compound in which a group-O-(CH2)2-OH is attached to an 
aromatic ring;  
- 2,3-dihydrobenzofuran, a compound in which a -(CH2)2-O- substituent is linked to 
two adjacent carbons of the benzene ring, forming a five atoms ring;  
- 2-indanol, characterized by the presence of an –OH group which gives the molecule 
a more polar character compared to other substrates.  
- phthalan, an isomer of 2,3-dihydrobenzofuran, in which the linked substituent is the 
group   -(CH2)-O-(CH2)–. 
 
The antioxidant potential of these molecules was evaluated both in vitro, using the 
DPPH assay, and ex vivo on cardiomyoblast cell line H9c2 subjected to oxidative 
stress induced by sodium arsenite. 
2) The recombinant expression of ToMO in the GRAS host microorganism 
Bacillus subtilis. 
 
To this purpose ToMO gene cluster was cloned in two different shuttle vectors, a 
non-integrative plasmid indicated as pHT01, and Pr19 that allows instead the direct 
integration of the recombinant gene in B.subtilis chromosomal DNA through single 
crossing-over. 
 
3) Expression and purification of the Baeyer Villiger 3,6-diketocamphane 1,6 
monooxygenase (3,6 DKCMO) and its flavin reductase component from 
Pseudomonas putida NCIMB 10007. 
 
This part of my project was performed in the Laboratory of Prof. Jennifer Littlechild at 
the Exeter Biocatalysis Centre, Biosciences, College of Life and Environmental 
Sciences at the University of Exeter, UK. 
The biochemical characterization of this multicomponent enzyme is important  to 
understand the future biotechnological potential of this protein for the 
oxyfunctionalization of aromatic compounds of industrial interest. 
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Figure 8: The aromatic compounds selected as substrates for 
the ToMO-catalyzed hydroxylation reaction to produce novel 
antioxidant phenols and catechols. 
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Chapter 2 – Material and Methods 
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2.1 Bacterial strains 
Escherichia coli strain JM109 was from Novagen and was used for the 
recombinant expression of ToMO. The genotype is: recA1 supE44 endA1 hdsR17 
gyrA96 relA1 thi ∆(lac-proAB). 
Escherichia coli strain Top10 was purchased from Invitrogen. The genotype is F- 
mcrA Δ(mrr-hsdRMS-mcrBC) φ80lacZΔM15 ΔlacX74 nupG recA1 araD139 Δ(ara-
leu)7697 galE15 galK16 rpsL(StrR) endA1 λ-. 
Bacillus subtilis strain AZ54 (w.t.) and strain MW10 (protease deficient) were a 
kind gift of Dr. Rachele Isticato (Department of Structural and Functional Biology, 
University Federico II of Naples). The genotypes are respectively: PY79 trpC2 metC3 
and  apr his hpr eglS∆(102) bglT/bglS∆Er. 
BL21(DE3) were purchased from Novagen, genotype: 95 F- ompT hsdSB (rB-mB-
) gal dcmrne131 (DE3). 
 
2.2 Bacterial culture media 
LB (Luria Bertani), was prepared as described by (69) 
M9 minimal salt medium was prepared as described by (69)  
TY (Tryptone yeast medium): this medium was used for agar plates of B. subtilis and 
prepared as described in (69).  
TB (Terrific both): for this medium 12g of tryptone, 24 g of yeast extract, 4g of 
glycerol were added in a final volume of 1L. 
 
2.3 Antibiotics 
Ampicillin (Amp) was purchased from Sigma and used at a concentration of 100 
g/mL. 
Chloramphenicol (CF) was purchased from Sigma and used at a concentration of 
5g/mL. 
2.4 Proteins 
Catechol 2,3 dioxygenase was purified (Department of Structural and Functional 
Biology, University Federico II, Naples, Italy) according to the procedure described in 
Viggiani et al (70). 
 
2.5 Plasmids 
pGEM3Z/tou wt and mutants. These plasmids were prepared as previously 
described (36,37). 
pHT01 was supplied by Dr. Rachele Isticato (Department of Structural and 
Functional Biology, University Federico II, Naples, Italy). 
Pr19. Plasmid Pr19 was supplied by Dr. Rachele Isticato (Department of Structural 
and Functional Biology, University Federico II, Naples, Italy). 
 
 
2.6 Plasmidic DNA Purification 
Plasmidic DNA was purified using the QIAprep spin miniprep kit for mini preparation. 
 
2.7 Purification of DNA fragments from agarose gel. 
The Wizard PCR Preps DNA Purification System from Promega was used. 
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2.8 Preparation of competent cells and transformation of E. coli. 
A single, well-isolated colony was picked, inoculated into 5 mL of LB/amp and 
incubated at 37oC up to 0.6 OD600. 1 mL was then withdrawn and centrifuged for 3 
min at 4 oC at 12,000 rpm. The pellet was suspended into 100 μL of TSS (10% PEG, 
5% DMSO, 50 mM MgCl2 in LB). 50 ng of purified plasmidic DNA was added to the 
cell suspension and put on ice for 30 min. 1 mL of LB was then added and the 
sample was incubated for 1h at 37°C. After centrifugation, 1mL of supernatant was 
removed, the pellet suspended in 100 L and plated on ampicillin containing LB/agar 
plates. The plates were incubated at 37oC, overnight. 
 
2.9 Preparation of competent cells and transformation of Bacillus subtilis. 
Competent cells of B. subtilis were thawed by incubating for 5 minutes the frozen 
tubes in a 37°C water bath. One volume of SpII (0.3% potassium acetate, pH 7.0 + 
2mM EGTA) was added to the thawed cells. 
In a sterile test tube competent cells (0.2~0.5 mL) were added to a purified plasmidic 
DNA preparation (ca. 1g) and incubated in a roller drum at 37°C for 45 minutes. The 
cell suspension was plated on selective agar plates. 
 
2.10 Genomic DNA extraction from Bacillus subtilis. 
A colony of B. subtilis was inoculated in 4 mL of LB containing cloramphenicol (5 μg 
/mL) and incubated overnight at 37°C. The cell suspension was then centrifuged for 
15 min at 3,500 rpm at 4°C and the supernatant was discarded. 
The cell pellet was suspended in 1.6 mL of Lysis Buffer (0.5 M NaCl, 5 mM EDTA pH 
8.0). A spatula tip of lysozyme powder was added; the sample was mixed by 
inversion and incubated at 37° for 10 minutes. 
45 μl of 20% Sarcosyl were added to the sample which was then incubated for 5 min 
at 37°C. The sample was extracted twice with phenol/chloroform. The resulting 
aqueous phase was transferred to a clean tube; 50 μl of 3M NaAc pH 6.0 and 1.5 mL 
of 96% Ethanol were added and the genomic DNA was precipitated by centrifugation 
at 13,000 rpm for 10 min at 4°C. The resulting pellet was dried for 10 min at 37°C 
and suspended in 200 L in nuclease-free water. 
 
2.11 Restriction endonucleases  
Restriction endonucleases were purchased from New England Biolabs (NEB). 
 
2.12 Isolation of plasmid DNA from Bacillus subtilis 
Plasmidic DNA was purified using the QIAprep spin miniprep kit for mini preparation. 
 
2.13 SDS-PAGE. 
Electrophoresis was performed as proposed by Leammli (71). The percentage of 
polyacrylamide was 18% in resolving gel and 6% for the stacking gel. 
 
 
2.14 Whole-cell assays 
Whole-cell assays were performed using E. coli JM109 cells transformed with the 
plasmid of interest. Recombinant strains were routinely grown in LB medium 
supplemented with 100 μg/mL ampicillin at 37°C to an optical density at 600 nm of 
0.6. Expression of the recombinant proteins was induced with 0.1 mM IPTG at 37°C 
in the presence of 0.2 mM Fe(NH4)2(SO4)2; this latter was necessary for the 
assembly of the iron-containing catalytic center of the recombinant ToMO. 
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One hour after induction, cells were collected by centrifugation and suspended in M9 
minimal medium containing 0.4% glucose, from here on indicated as M9-G. The 
hydroxylase activity of cells was measured using phenol as the substrate and 
monitoring the production of catechol in a continuous coupled assay with 
recombinant C2,3O from Pseudomonas sp. OX1, which cleaves the catechol ring 
and produces 2-hydroxymuconic semialdehyde. This can be monitored 
spectrophotometrically at 375 nm. The specific activity of cells on phenol was 
determined by their incubation at an OD600 of 0.1 to 0.5 in a quartz cuvette in a final 
volume of 600 μL of M9-G, 1 mM phenol, and saturating amounts of C2,3O (3 U). 
The rate of formation of catechol (ε375 = 29,100 M
-1 cm-1) was measured. Specific 
activity was expressed as the number of mU/OD600, with one milliunit being defined 
as the amount of catalyst that oxidized 1 nmol of phenol per minute. 
 
2.15 Catalytic assays on crude extracts of Bacillus subtilis  
To verify the effective expression of the ToMO recombinant system in B.subtilis, a 
single clone of this microorganism was picked from the transformation plate and 
grown at 37°C in a final volume of 250 mL of LB containing chloramphenicol. 60 mL 
of cell suspension were withdrawn from the growing culture at 1.5h, 3h and 16h after 
the addition of 0.2 mM Fe(NH4)2(SO4). The culture was supplemented with iron at an 
optical density of 0.9 OD600. At specific time intervals cells were collected by 
centrifugation and the resulting pellets were suspended in 50 mM Tris HCl pH 7.5 
and disrupted by sonication (10 min effective: 30 sec ON , 30 sec OFF ). 
The cell suspension was centrifuged for 20 min at 4oC at 12,000 rpm and the 
supernatant filtered through a 0.45 μm filter. The assay mixture contained, in a ﬁnal 
volume of 600 L, variable amounts of cell extract, 1mM phenol and 500 M NADH. 
Discontinuous coupled assays were performed; After 15, 30, 120 and 240 minutes of 
incubation, 3 U of catechol 2,3-dioxygenase were added to each sample in order to 
convert the catechol, the product of the ToMO-catalyzed hydroxylation of phenol, to 
2-hydroxymuconic semialdehyde, a product whose formation can be monitored at 
410 nm.  
 
 
2.16 Total RNA puriﬁcation and RT-PCR  
Total RNA was extracted with the TRI-Reagent kit (Sigma), using the manufacturer’s 
protocol. Samples were then incubated with 10 U µL−1 DNaseI (Boehringer) at 37°C 
for 30 min and subjected to an acid phenol:chloroform extraction. RNA was 
recovered from the aqueous phase by precipitation with 3 M sodium acetate pH 5.3. 
Total RNA was dissolved in 60 µL of diethylpyrocarbonate-treated H2O and stored at 
−80°C. RNA concentration was estimated spectrophotometrically by measuring the 
absorbance at 260 nm (1 OD260nm = 40 µg mL
−1) (69). The integrity of RNA was 
veriﬁed on a denaturing 1.5% agarose gel. RT-PCR reactions were performed using 
the “Access RT-PCR System” kit (Promega), using 200 ng of RNA as template for 
each reaction and ampliﬁcation products were examined on 1% agarose gels.  
RT-PCR reactions were performed using the following primers: 
 5-GATTATTACACGCCACTGGAAT-3 (upstream); 5-GTCGCCATGTCCCACCTC-3 
(downstream) for the amplification of orf touA. 
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2.17 Identification of the reaction products of ToMO-catalyzed hydroxylation of 
non-natural aromatic substrates. 
Cells of E. coli strain JM109 transformed with either plasmid pBZ1260 or variant 
E103G/F176A, were routinely grown in LB to which ampicillin was added to a final 
concentration of 100 g/mL (LB/amp). Three well-isolated colonies were picked from 
LB/amp agar plates, inoculated into 12.5 mL of LB/amp in a sterile 50 mL Falcon 
Tube and incubated in constant shaking at 37oC up to 0.6 OD600;  the preinoculum 
was diluted 50-fold in two 500 mL Erlenmeyer flasks containing each 250 mL of 
LB/amp, and incubated in constant shaking at 37oC up to 0.7-0.8 OD600. Expression 
of the recombinant ToMO proteins was induced with 0.2 mM IPTG at 37°C in the 
presence of 0.2 mM Fe(NH4)2(SO4)2; this latter was necessary for the assembly of 
the iron-containing catalytic center of the recombinant ToMO. After 1 hour of 
induction, cells were collected by centrifugation (1,880 x g for 15’ at 4°C), 
resuspended in M9 medium containing 0.4% glucose (M9-G) at a final concentration 
of 6 OD600 and incubated with 2 mM of either phthalan, 2-phenoxyethanol, 2,3 
dihydrobenzofuran or 2-indanol dissolved in methanol  (final methanol concentration 
is of 2%). After a 14h incubation at 28°C at 230 rpm, cells were collected by 
centrifugation at 1,880 x g for 15’ at 4°C; an aliquot of the cell-free supernatants was 
loaded on HPLC to check for the presence of hydroxylated products before their 
purification. To this purpose, an HPLC system equipped with a Waters 1525 binary 
pump coupled to a Waters photodiode array detector was used. Hydroxylated 
products and substrates were separated using a Ultrasphere C18 reverse-phase 
column (4.6 by 250 mm; pore size, 5 m). Separation was carried out at a flow rate of 
1 mL/min by using a two-solvent system consisting of a 0.1% formic acid solution in 
water (solvent A) and a 0.1% formic acid solution in methanol (solvent B). 
Compounds were separated using a 3-min isocratic elution with 10% solvent B, 
followed by a 20-min linear gradient from 10 to 75% solvent B and an isocratic 5-min 
step at 98% solvent B. 
 
 
2.18 Purification of reaction products 
Cell-free supernatants prepared as described above were extracted twice with ethyl 
acetate added in a 1:2 ratio compared to the aqueous phase. The organic phase was 
recovered, dried with a Rotavapor apparatus, and the pellet is dissolved in 100% 
methanol and stored at -20°C. For further purification the sample is first diluted to a 
final 10% concentration of methanol and then loaded on HPLC. In this case an 
Econosil C18 reverse-phase column (250 by 10 mm) is used. Separation is carried 
out at a flow rate of 2 mL/min by using a two-solvent system consisting of a 0.1% 
formic acid solution in water (solvent A) and a 0.1% formic acid solution in methanol 
(solvent B). Compounds are separated using a 10-min isocratic elution with 10% 
solvent B, followed by a first 10-min linear gradient from 10 to 40%, a second 10-min 
linear gradient from 40% to 75%, a third 5-min gradient from 75% to 90% and a final 
isocratic 10-min step at 90% of solvent B. Each peak of interest was individually 
collected, concentrated, and stored at -20°C. 
 
 
2.19 NMR and mass spectrometry analysis of catechols  
For NMR analysis (performed by Dr. Alessandro Pezzella at the Department of 
Chemistry, University Federico II of Naples)  aliquots of the purified cell-free 
supernatants prepared as described in paragraph 2.3 were lyophilized. The residues 
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obtained were directly used for NMR analysis in deuterated methanol Chemical shifts 
are reported in  values (ppm) downfield from tetramethylsilane. 1H NMR spectra 
were recorded at 600, 400, or 300 MHz, and 13C NMR spectra were recorded at 75 
MHz. 1H and 13C distortion less enhancement by polarization transfer heteronuclear 
single-quantum correlation and 1H and 13C heteronuclear multiple-quantum 
correlation (HMBC) experiments were run at 600 and 400 MHz, respectively, on 
instruments equipped with a 5 mm 1H/broadband gradient probe with inverse 
geometry using standard pulse programs. The HMBC experiments used a 100-ms 
long-range coupling delay. Hydroxyl group positions were deduced on the base of 
the spin-coupling pattern in the aromatic region of the 1H NMR spectra  
 
 
2.20 DPPH assay. 
α,α-diphenyl-β-picrylhydrazyl (DPPH) free radical scavenging method is generally the 
first approach to evaluate the antioxidant potential of a compound (72) DPPH is a 
stable free radical with max at 515 nm (purple, 517 in methanol=12 mM
-1cm-1). Its 
conversion to DPPH (yellow) is used as a readout of radical scavenging of an 
antioxidant compound. In a final volume of 1 mL of 100% methanol, different 
concentrations of our phenolic compounds and 0.1mM of a freshly prepared DPPH 
solution in 100% methanol were added. It is important to note that, as recommended 
by Kedare and coauthors (72), the initial DPPH concentration should give 
absorbance ≤ 1.0. The reaction was allowed to proceed for a maximum time of 30 
minutes at RT, in any case till completion, and followed at = 515nm.  
 
2.21 Cell cultures and extracts  
H9c2 cells were maintained in Dulbecco’s modified Eagle medium supplemented 
with 10% fetal bovine serum, 2mM L-glutamine, 1% v/v penicillin/streptomycin 
solution (100 U/ml) (Sigma-Aldrich, Milano, Italy) at 37°C in 5% CO2 incubator. To 
induce oxidative stress, cells were treated with 250 µM of an aqueous solution of 
sodium arsenite (Sigma Aldrich).  
 
2.22 Immunofluorescence 
Cells were seeded onto coverslips (25.000 cells in 300 l of DMEM for each 
coverslip), grown for 48 hours, incubated for 3h with different concentrations of the 
novel catechols, and subsequently treated with250 µM of sodium arsenite for 1.5h. 
As negative and positive control of the stress effect, cells were treated with either 
buffer or 250µM of sodium arsenite, respectively. Cells were then fixed in 4% 
paraformaldehyde in PBS 1X for 15 min at room temperature and rinsed three times 
with PBS 1X. Quenching was performed with 50mM NH4Cl in PBS 1X. After washing, 
cells were permeabilized using 0.1% Triton X100 in PBS 1X for 30 min and blocking 
was performed by adding 5% albumine bovine serum in PBS 1X for 1h at room 
temperature. PABP monoclonal antibody (Sigma Aldrich) was diluted (1 g/mL) in 
blocking buffer and incubated overnight at 4°C. After washing in PBS 1X, cells were 
incubated with secondary antibody Cy3 conjugated goat anti-mouse IgG (1:1,000 
dilution) (Jackson Immuno Research Laboratories). For nuclear counterstaining, cells 
were incubated with DAPI in PBS 1X 0.1 μg/mL for 10 min at room temperature. After 
washing, coverslips were mounted in 50% glycerol in PBS 1X. Images were captured 
using a Zeiss confocal laser-scanning microscope LSM 510 using suitable lasers. 
Image analyses on stress granules was performed using “Stress granule counter” 
and “Analyze particles” ImageJ (http://rsbweb.nih.gov/ij/index.html) plugins. Nuclear 
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counterstaining was used to count the total number of cells. Statistical analyses were 
performed using GraphPad (Prism) software ver. 5.0. 
 
 
2.23 MTT Assay 
Cells were seeded on 96-wells plates (2,500 cells in 100 μL of DMEM) and grown at 
37°C overnight. Catechols were added at the same concentrations used for 
immunofluorescence experiments.  After 72 h of incubation, 10 μL of a MTT stock 
solution in PBS 1X were added to the cells to a final concentration of 0.5 mg/mL in 
Dulbecco’s modified Eagle’s medium without red phenol (final volume 100 μL). After 
4h of incubation, the MTT solution was removed and MTT formazan salts were 
dissolved in 100 L of 0.1 N HCl in anhydrous isopropanol. Cell survival was 
expressed as the absorbance of blue formazan measured at =570 nm with an 
automatic plate reader (Victor 3TM Multilabel Counter; Perkin Elmer, Shelton, CA, 
USA). Standard deviations were always <5% for each experiment. 
 
2.24 Ethidium bromide and acridine orange assay 
An ethidium bromide and acridine orange (EB/AO) staining assay was performed to 
identify and quantify apoptotic cells (73).  
AO is a nucleic acid selective fluorescent dye that permeates all living cells 
highlighting the nuclei by green fluorescence, while EB is only taken up by cells when 
cytoplasmic membrane integrity is compromised, staining red apoptotic nuclei. Cells 
were seeded in 6-wells plates (200,000 cells in 2 mL of DMEM) and grown for 48h. 
Cells were incubated with the appropriate concentrations of antioxidant catechols for 
3h, before or after treatment with sodium arsenite (250 μM for 1.5 h) and then 
trypsinized, collected by centrifugation, and washed with ice cold PBS 1X. Then, cells 
were re-suspended in 100μL of cold PBS 1X and incubated with 5μL of the EB/AO 
dye mixture (100 μg/mL each of AO and EB in PBS 1X) at 37°C for 20 min. Stained 
cells were placed on a microscope slide and covered with coverslips. Images were 
taken at 200 X magnification. Both apoptotic (red) and live (green) cells were counted 
in five microscopic fields, to obtain the percentage of apoptotic cells.  
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Chapter 3 – Results and Discussion Section I 
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3.1.1 ToMO from Pseudomonas sp. OX1 for the biosynthesis of phenolic 
antioxidants.  
Oxidative stress is a consequence of the imbalance between the production of 
reactive oxygen species (ROS) and the ability of cells to counterbalance this 
physiological event through the action of antioxidants (74,75). Much attention has 
been dedicated by the scientific community to both antioxidant phenols and 
catechols, molecules -that among others- can be easily functionalized. Particular 
interest has also been devoted to the set-up of biocatalytic processes to produce 
these compounds to avoid the problems encountered with the chemical synthesis. 
The biocatalytic potential of the ToMO multicomponent monooxygenase from Ps. sp. 
OX1 has been recently confirmed by its use for the production of tyrosol and 
hydroxytyrosol, strong antioxidants commonly found in extra virgin olive oil, starting 
from a low cost, commercially available aromatic precursor such as 2-phenylethanol 
(38). 
The versatility of ToMO and the bioinformatic strategy recently developed for this 
system, allow the use of this enzyme not only for the optimization of the 
bioconversion of 2-phenylethanol in hydroxytyrosol, but also for the hydroxylation of 
other monocyclic aromatic compounds, which are not natural substrates of this 
enzyme, in order to synthesize novel antioxidant phenols and catechols for food and 
pharmaceutical industries.  
Therefore, it was decided to investigate the potential use of ToMO for the 
hydroxylation of the following molecules: 2-phenoxyethanol, 2,3-dihydrobenzofuran, 
phthalan and 2-indanol (Fig.8). As underlined in the Introduction section these 
substrates were chosen on the basis of i) their similarity with ToMO natural 
substrates and ii) the different nature of the substituents bound to the aromatic ring 
which may influence the biological activity of their hydroxylated derivatives obtained 
from the ToMO-catalyzed reaction. 
 
3.1.2 Identification and characterization of the products obtained from the 
ToMO-catalyzed hydroxylation.  
2-phenoxyethanol, 2,3-dihydrobenzofuran, phtalan and 2- indanol were purchased 
from Sigma. Their purity was checked by HPLC, as described in Materials and 
Methods. For each compound the corresponding UV-Vis spectrum was recorded. 
max for each substrate is reported in Fig.9.  
In order to verify the stability at room temperature of these aromatic compounds their 
evaporation rate was checked (Fig. 10 and Table 1) under experimental conditions 
that simulated the typical biotransformation assays, i.e. using a final concentration of 
1 mM of each substrate of interest dissolved in M9 medium containing 0.4% glucose 
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Figure 9: 
A) HPLC elution profiles of each substrate 
and B) the corresponding UV-vis spectrum. 
A 
B 
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                       2,3-dihydrobenzofuran  Phtalan  2-phenoxyethanol  2-indanol  
time(h)  % of substrate  
% of 
substrate  
% of substrate  
% of 
substrate  
0  100  100  100  100  
1  80,5  100  100  100  
2  65,48  92,3  100  100  
3  65,4  88,1  100  100  
4  60,9  84,2  100  100  
19  26,4  62,4  100  95,6  
Table 1 : In this table, for each compound, time and corresponding percentage of 
residual substrate are reported. 
Figure 10: Evaporation curves of the aromatic substrates as a function of time.  
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(from now on indicated as M9-G), and at a temperature of 28°C. The evaporation 
rate was evaluated spectrophotometrically, by recording the spectrum at different 
time intervals and comparing the corresponding ABS values at max. As evident from 
the analysis of the data presented in Table 1, 2,3-dihydrobenzofuran and phthalan 
are more volatile than 2-indanol and 2-phenoxyethanol. This is an important 
consideration to take into account, because, due to their volatility, it could be 
necessary to increase their concentration in the growth medium for a future 
optimization of the biotransformation assays and for a correct estimation of products 
yield. Even though 2-indanol and 2-phenoxyethanol are quite stable under the 
experimental conditions used, we decided to increase the initial concentration of all 
compounds used in the following biotransformation processes up to 2 mM. 
Cells of E. coli strain JM109 transformed with plasmid pBZ1260, expressing the 
complete wt tou gene cluster, were grown in LB and ToMO expression was induced 
as described in Materials and Methods. After 1 hour of induction, cells were collected 
by centrifugation, resuspended in M9-G at a final concentration of 6 OD600 and 
incubated with 2 mM of either 2-phenoxyethanol or phthalan or 2-indanol or 2,3-
dihydrobenzofuran. 
After incubation for different time intervals (0, 30 min, 1h, and 16 h) at 30°C under 
constant shaking (220 rpm), samples were withdrawn, cells were collected by 
centrifugation, and an aliquot of exhausted medium was loaded on HPLC to check 
for the presence of hydroxylated products. HPLC analysis of these samples was 
performed as described in section 2.2. As it is evident from Fig. 11, where only 
samples from the 16 h incubation have been reported for clarity, wt ToMO was able 
to hydroxylate 2-phenoxyethanol, phthalan, and 2,3-dihydrobenzofuran. Three 
different peaks eluting respectively at 10.38 min (λmax= 287.5 nm), at 12.6 min 
(λmax=273.5nm) and 15.16 min (λmax=275.3nm) were evident in the case of 2-
phenoxyethanol (Fig.11A). When using phthalan as substrate a single peak was 
eluted at 14.3 min (λmax=279.2 nm) (Fig. 11B). For 2,3-dihydrobenzofuran one single 
peak of product was evident from the chromatogram (Fig.11C) eluting at 14 min 
(λmax=299nm). 
No evident hydroxylation product was instead observed when the substrate used for 
the bioconversion was 2-indanol, thus confirming the results obtained from the 
manual docking of these aromatic substrates into the active site of ToMOA 
performed in collaboration with Dr. Eugenio Notomista at the Department of Biology 
(data not shown). For the bioconversion of 2-indanol the ToMO variant E103G/F176A 
was used whose expression and induction were performed as described above for wt 
ToMO system. HPLC chromatogram in Fig. 12 shows in this case the presence of 
two peaks of hydroxylated products eluting respectively at 13 min (λmax= 280.3 nm) 
and 10 min (λmax=288nm), thus indicating that in this mutant a wider cavity of the 
active site permits the entrance of 2-indanol and allows its hydroxylation.  
Once checked for the presence of hydroxylation products in the reactions involving 
these aromatic compounds, the exhausted media obtained from each bioconversion 
were further purified through organic extraction, as described in Materials and 
Methods. Samples were then loaded on a preparative HPLC C-18 column, each 
peak was manually collected, lyophilized and analyzed by NMR and mass 
spectrometry by Dr. Alessandro Pezzella at the Department of Chemistry, University 
Federico II of Naples (see Materials and Methods).  Results are presented in Table 2. 
All hydroxylated compounds were identified except for the product obtained from 2,3-
dihydrobenzofuran; in this case the lyophilization   
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A) 
Figure11: HPLC chromatograms of aliquots of exhausted media obtained after 16 hours 
of wt ToMO-catalyzed bioconversion of A) 2-phenoxyethanol, B) phthalan, C) 2,3-
dihydrobenzofuran. 
  
 
 
C) 
A) 
B) 
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Figure 12: HPLC chromatogram of an aliquot of exhausted medium obtained after 
16 hours of E103G/F176A ToMO variant-catalyzed bioconversion of 2-Indanol.  
 
50 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2: Hydroxylation products obtained from ToMO-catalyzed reaction on each 
aromatic substrate. Hydroxyl group positions were deduced on the base of the spin-
coupling pattern in the aromatic region of the 1H NMR spectra (see Materials and 
Methods). 
2-Indanol 2-Phenoxyethanol Phthalan 
2,3- 
Dihydrobenzofuran 
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process lead to a mixture of oxidized compounds whose structure could not be 
univocally assigned. Preliminary data showed that this non-purified mixture had 
antioxidant activity both in vitro and ex vivo (data not shown). However, it was 
decided not to proceed any further on this mixture for the difficulty in determining 
both its exact composition and concentration. 
To evaluate the concentration of the novel hydroxylated compounds obtained from 
ToMO-catalyzed reaction we selected, for each of them, a similar compound whose 
UV-vis spectrum and corresponding extinction coefficient is available in literature 
(Fig. 13). All the spectroscopic data used for calculations were obtained from 
“Organic Electronic Spectral Data” book series (Wiley eds.). 
 
3.1.3 In vitro assessment of the antioxidant potential: the DPPH assay. 
The capacity of the new hydroxylated compounds to scavenge the stable radical 2,2-
diphenyl-1-picrylhydrazyl (DPPH) was determined spectrophotometrically by 
measuring the loss of absorbance of DPPH at =515 nm (see Materials and Methods 
for details). In a final volume of 1mL of methanol, 0.1 mM DPPH and different 
concentrations of each hydroxylated compound were added, and the loss of ABS515 
was monitored for 30 minutes. At this time, once the ABS515 value is stable, residual 
DPPH (DPPHres) is calculated as: 
 
DPPHres= [DPPH]res/[DPPH]t=0 
 
The concentration of hydroxylated compound added in each experiment was plotted 
against the DPPH effectively reduced calculated as [DPPHred]=1-
([DPPH]res/[DPPH]t=0) (Fig. 14A). The concentration that causes a decrease in initial 
DPPH concentration by 50% was defined as EC50 and was obtained by a non-linear 
regression of the experimental curves using the Graphpad Prism software. Each 
EC50 is the result of at least two independent experiments. 
Once obtained the EC50 value for a specific compound we estimated also at that 
specific concentration the time needed to reach a stable value of the ABS at 515 nm 
(the plateau), thus introducing a parameter indicated in literature as TEC50 (Fig.14B) 
(76,77), At this point we calculated what has been defined by Sanchez-Moreno and 
coworkers (76) as the “antiradical efficiency (AE)” a parameter that is expressed by 
the following formula: AE= 1/ (EC50 X TEC50). 
In all experiments described in this and in the following paragraphs, known 
antioxidants as tyrosol and hydroxytyrosol (Fig. 5, Introduction) have been always 
tested, as reference molecules, in parallel with our novel hydroxylated compounds.  
Results are shown in Table 3, where it is evident that some among the novel phenols 
and catechols produced by the ToMO-catalyzed reaction on non-natural aromatic 
substrates show an antiradical efficiency comparable to both the natural phenolic 
antioxidant hydroxytyrosol and to carotenoids (Table 4). Interestingly, compounds 
such as tyrosol, which has been reported to be antioxidant in vivo (78), 2-(3’-
hydroxyphenoxy)-ethanol, 5-hydroxy-2-indanol, and 3-hydroxyphtalan (Fig.13) were 
almost non responsive to the DPPH assay causing negligible losses of ABS515 even 
when used at mM concentrations. 
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Figure 13: Hydroxylated products obtained from the ToMO-catalyzed reaction and similar 
compounds whose extinction coefficient is available in literature. 
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Table 3: Antioxidant efficiency (AE) for each hydroxylated compound tested. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4: Antioxidant efficiency (AE) of several carotenoids (75). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Compound EC50(µM) 
µM Antioxidant/ 
µM DPPH 
TEC50(min) AE  
 
Hydroxytyrosol 0,22 16 0,28 
2-(2’-hydroxyphenoxy)-
ethanol 
1 24,5 0,04 
2-(4’-hydroxyphenoxy)-
ethanol 
0,36 19,5 0,14 
5,6-hydroxy-2-indanol 0,41 18 0,135 
Compound AE  
 
Lycopene 0,250 
α-Carotene 0,047 
β-Carotene 0,037 
β-Cryptoxanthin 0,042 
Lutein 0,011 
Zeaxanthin 0,018 
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Figure 14: 
A) A typical [DPPH]red vs. concentration curve when using 
hydroxytyrosol in the DPPH assay. 
B) A [DPPH]res vs. time (min) curve when using hydroxytyrosol in 
the DPPH assay. 
 
B) 
A) 
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3.1.4 Antioxidant activity on H9c2 cells. 
The antioxidant activity of the novel hydroxylated compounds was evaluated on a 
selected eukaryotic cell line, the embryonic rat cardiomyoblast cell line H9c2, 
subjected to a mild oxidative stress induced by sodium arsenite. H9c2 cells are 
currently used as a model system of non-malignant and cardiac-like cells, suitable to 
study cellular response to oxidative damage. The experiments performed on this cell 
line were performed in collaboration with Dr. Eliodoro Pizzo, Dr. Carlo Di Cristo and 
Dr. Carmen Sarcinelli (Department of Biology, University of Naples Federico II). 
Prior to analyze the antioxidant potential of our novel compounds, we assessed their 
cytotoxicity by evaluating i) the influence on the MTT assay and ii) the apoptotic 
effect on treated cells. 
MTT assay is a colorimetric assay that allows to analyze cell survival by measuring, 
after a specific treatment, the residual activity of mitochondrial enzymes which 
reduce the tetrazolium dye, MTT, to its insoluble form, formazan, thus giving a purple 
color.  
Cells were plated on 96-well plates at a density of 2,500 cells in 100 μL of medium 
containing either novel hydroxylated compound at an optimized concentration ≥ EC50 
(5 to 10 M higher than the EC50 value, see Materials and Methods for details). When 
this value was not available, as in the case of tyrosol, 2-(3’-hydroxyphenoxy)-ethanol, 
5-hydroxy-2-indanol, and 3-hydroxyphtalan (Fig.13), two arbitrary concentrations of 
40 and 80 M were tested. 
After 72 h of incubation, 10 μL of a MTT stock solution in 1X PBS were added to the 
cells to a final concentration of 0.5 mg/mL in Dulbecco’s modified Eagle’s medium 
(final volume 100 μL). After a 4h incubation, the MTT solution was removed and MTT 
formazan salts were dissolved in 100 L of 0.1 N HCl in anhydrous isopropanol. Cell 
survival was expressed as the ABS of blue formazan measured at 570 nm with an 
automatic plate reader (Victor 3TM Multilabel Counter; Perkin Elmer, Shelton, CA, 
USA). (79). Standard deviations were always <5% for each experiment. 
Data obtained showed that our compounds, as well as their non-hydroxylated 
precursors (data not shown), induce a minor reduction of cell viability (Fig. 15). 
Residual viability for any compound tested was never lower than 92% and in some 
cases cell viability appeared to be even improved (Fig.15).  
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Figure 15: Cell survival is expressed as ABS570 of blue formazan. Standard 
deviations were always <5% for each experiment. 
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To examine the effect of our compounds on cell apoptosis, ethidium bromide and 
acridine orange staining was used to identify apoptotic nuclei (Fig. 16A). Acridine 
orange (AO) permeates intact cells and stains all nuclei green, while Ethidium 
bromide (EB) stains apoptotic nuclei with red fluorescence when cytoplasmic 
membrane integrity is compromised. Experiments were performed as described in 
Materials and Methods. Under our conditions a basal apoptotic frequency in non-
treated cells was observed which corresponded to a value of 13 ± 7%. Incubation 
with hydroxytyrosol reduced the percentage of apoptotic nuclei to a value of 11 ± 
4.1%. Hydroxylated compounds did not significantly alter the occurrence of apoptotic 
nuclei (blue bars, Fig.16B). Incubation with either 5-hydroxy-2-indanol or 5,6-
hydroxy-2-indanol or 2-(4’hydroxyphenoxy)-ethanol or 2-(3’hydroxyphenoxy)-ethanol 
provided a percentage of apoptotic nuclei of 11 ± 4.8%, 11± 1.7%, 12± 6.3%, 7 ± 
4.2% respectively. However, when incubated with either 2-(2’hydroxyphenoxy)-
ethanol or 3-hydroxyphtalan the percentage of apoptotic nuclei were of 18 ± 3.5% 
and 18 ± 3.8% respectively. 
Oxidative stress in this cell line was induced by adding 250 µM of sodium arsenite for 
1.5 hours (Materials and Methods). Exposure of cells to arsenite results in numerous 
effects including apoptosis, malignant cell transformation, cell cycle arrest, induction 
of stress response, inhibition of cell proliferation and cytoskeletal injury (80). The 
exact mechanism of arsenite’s toxicity is currently unknown. Several possibilities 
have been proposed including alterations in DNA repair and methylation and the 
generation of ROS. Arsenite also has the ability to bind to protein thiol groups. It is 
believed that the binding of thiol groups, as well as ROS generation, can alter many 
protein functions. Thus, the distinct and diverse effects of arsenite may result from 
the activation and/or inactivation of a variety of signal transduction pathways in cells 
(80). Following oxidative stress (red bars, Fig.16B), the percentage of apoptotic 
nuclei in non-treated cells showed a two-fold increase, giving a value of 31±2.9%. A 
3h pre-treatment with our hydroxylated compounds (Materials and Methods) lead to 
different results: when cells were pre-treated with 5-hydroxy-2-indanol, 5,6-hydroxy-
2-indanol, 2-(4’hydroxyphenoxy)-ethanol and  2-(2’hydroxyphenoxy)-ethanol, the 
occurrence of apoptotic nuclei decreased, thus indicating a protective effect of these 
compounds. On the other hand, the use of either tyrosol, hydroxytyrosol, 2-
(3’hydroxyphenoxy)-ethanol or 3-hydroxypthalan led to a slight increase in cell 
apoptosis. 
It is worth to note that even if a two-fold increase of cell apoptosis was observed in 
non-treated cells incubated with 250 M of sodium arsenite, the value obtained is still 
compatible with a general viability of the cell population analyzed, thus allowing the 
use of this oxidant for the experiments of immunofluorescence described in the next 
paragraph. 
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Figure 16:  
A) Apoptotic cells under physiological (left panel) and oxidative stress conditions 
(right panel).  
B) Cell survival was evaluated from ABS570 of blue formazan. Standard deviations 
were always <5% for each experiment. 
59 
As underlined before, exposure to sodium arsenite inhibits protein synthesis and 
activates multiple stress signaling pathways. When translation is initiated in the 
absence of a functional eIF2-GTP-tRNAi Met complex, the 40S ribosome stalls on 
the mRNA to form a 48S pre-initiation complex. These complexes composed by 40S 
ribosomes, initiation factors, and their associated mRNA transcripts accumulate in 
the cell cytoplasm to form what is usually referred to as “stress granules” (SGs) (81). 
To better investigate the antioxidant potential of our novel hydroxylated compounds  
we analyzed the occurrence and the number of stress granules (SGs) in H9c2 cells 
subjected to sodium arsenite-induced oxidative stress by using a specific antibody 
against PABP, a protein that binds to poly(A)tails of mRNA and regulates mRNA 
stability and protein translation. PABP is a prominent component of SGs (81).  
Experiments were performed as described in Materials and Methods. SGs number 
was examined by using suitable plugins for imaging software and a statistical 
analysis was applied to microscope images acquired. For each experiment, at least 
350-400 cells were analyzed.  
Immunofluorescence and confocal microscopy analysis revealed a 3.59 fold increase 
in SGs number of cells incubated with sodium arsenite, when compared to non-
treated cells (Fig. 17 A and B). Two-tailed Student’s t student analysis confirmed this 
statistical difference (p<0.05). No statistically significant difference was instead 
observed in SGs number in cells treated with our compounds, thus indicating that 
they do not increase the basal SGs number of non-treated cells. 
When sodium arsenite-stimulated cells were pre-treated with each of our 
compounds, a strong and statistically significant decrease in SGs number was 
observed (Fig. 17B) with a maximum effect obtained when using 40 M of 5,6-
hydroxy-2-indanol.  
p <0.05 for cells pretreated with: 
 -40 M of 2-(4’hydroxyphenoxy)-ethanol;( 
 -40 M of 3-hydroxypthalan; 
 -80 M of 5-hydroxy-2-indanol. 
 p<0.01 for cells pretreated with: 
- 90 M 2-(2’hydroxyphenoxy)-ethanol; 
- 2-(3’hydroxyphenoxy)-ethanol; 
- 80 M of 3-hydroxypthalan; 
- 25 M Hydroxytyrosol; 
- 40 M of 5,6-hydroxy-2-indanol; 
- 40 M of 5-hydroxy-2-indanol; 
- Tyrosol.  
In order to exclude a putative antioxidant role of the aromatic compounds used as 
substrates in the ToMO-catalyzed biosynthesis, their effect on SGs number in H9c2 
treated cells was also evaluated (data not shown). In these experiments no 
significant decrease in SGs number was observed, when compared with the control, 
thus excluding any antioxidant effect of the non-hydroxylated precursor of our 
compounds.  
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Figure 17: 
A) Immunofluorescent representative images of stress granules in physiological (left 
panel) and stress condition (right panel). 
B) Estimation of the number of stress granules in H9c2 cells in the presence and 
absence of the novel hydroxylated compounds. 
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3.2.1 The Industrial scale-up of ToMO-catalyzed hydroxylation: use of Bacillus 
subtilis as a GRAS host for the heterologous expression of oxygenase 
activities. 
The first step for a future industrial scale-up of ToMO-catalyzed hydroxylation of 
aromatic substrates to produce high-added value compounds is the use of a GRAS 
(Generally Recognized As Safe) host microorganism for the recombinant expression 
of this multicomponent monooxygenase. 
The system currently used for the recombinant expression of ToMO is one of the 
most widely used expression hosts, i.e. Escherichia coli. The techniques for protein 
overexpression in E. coli are well developed; nevertheless, the use of this 
microorganism for the recombinant expression is often related to the formation of 
inclusion bodies due to the inefficacy of its folding machinery.  Additional problems 
that strongly limit the use of this microbial host for the industrial scale-up of any 
bioprocess are related to the presence in its outer membrane of the 
lipopolysaccharide (LPS), an harmful endotoxin that complicates the purification 
process.  
As outlined in the Introduction section, Bacillus subtilis is a good alternative to E.coli, 
and, most importantly, the microorganism has been defined as GRAS and non-
pathogenic to humans ( 68). 
Recently, the ToMO system was used for the production of tyrosol, a strong phenolic 
antioxidant commonly found in extra-virgin olive oil, starting from 2-phenylethanol, a 
cheap and commercially available compound (38). Tyrosol belongs to a class of 
molecules commonly referred to as “nutraceuticals”, whose role in the prevention of 
diseases such as cancer and cardiovascular diseases is rapidly emerging (13). 
Due to the inability of wt ToMO to produce tyrosol as the sole isomer from the 
hydroxylation of 2-phenylethanol, a computational model was developed which 
provided a molecular explanation for this outcome. The bioinformatic analysis led to 
the identification of residue F176 as a major steric hindrance for the correct 
positioning of the reaction intermediate leading to tyrosol production. In fact, all the 
mutations at position 176 allowed ToMO to produce only tyrosol from 2-
phenylethanol. Moreover, the combination of mutations at position F176 with 
mutation E103G increased the kcat values on 2-phenylethanol. In conclusion, among 
the E103G/F176X variants prepared in the laboratory where this PhD project was 
developed, it was found that mutant E103G/F176T was one of the most efficient, 
allowing, in batch experiments, the conversion of about 50% of 2-phenylethanol into 
tyrosol in 2h (38.).  
In this chapter, the use of B. subtilis as a host for the recombinant expression of 
ToMO variant E103G/F176T is described, with the aim of investigating the potential  
use of this microorganism for the industrial scale-up of the bioconversion of 2- 
phenylethanol into tyrosol, previously validated in the strain JM109 of E.coli.  
The strategies used were i) to integrate the tou gene cluster in the genome of B. 
subtilis through single crossing over, and ii) to express the tou gene cluster in a B. 
subtilis compatible expression vector. 
The direct integration of a gene of interest in the genome of B. subtilis is the 
preferable approach from a biotechnological point of view because it generates a 
stable mutant strain whose selection does not need the use of antibiotics. However, 
the expression level of the recombinant protein might be too low to allow the effective 
evaluation of the potential use of this novel host strain for the bioconversion of 2- 
phenylethanol into tyrosol. As a consequence, a more “classical” approach was also 
attempted which involved the cloning of the tou gene cluster in a non-integrative 
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IPTG-inducible vector suitable for the heterologous expression of proteins in B. 
subtilis. 
 
3.2.2 Cloning of the tou gene cluster: integration into the genome of B. subtilis.  
The integration was intended to occur through a single crossing over mediated by the 
presence, at the 5’ of the tou gene cluster, of a specific constitutive promoter of B. 
subtilis. A constitutive promoter was selected because, generally, an inducible 
promoter leads to the use of expensive inducers for the fine-tuning of gene 
expression, a characteristic which can be considered prohibitive for an industrial 
scale-up of a biosynthetic process. In collaboration with Dr. Rachele Isticato 
(Department of Biology, University of Naples Federico II) we decided to use the B. 
subtilis rrnO promoter, which is a strong promoter for the rRNA transcription (82). The 
rrnO promoter is cloned in the pGEM–T Easy vector between the SphI and PstI sites 
(Fig.9A). rrnO promoter was excised from this vector and subcloned into a 
destination vector named Pr19. This latter consists of a 2,382 bp region of the pUC 
19 vector and a 1,400 bp region of the pJM03 vector, a pUC18 derivative containing 
a chloramphenicol resistance that can be expressed in B. subtilis (83).  
The tou E103G/F176T gene cluster is cloned into the SmaI site in pGEM-3Z vector 
(Fig. 18B) (38). 
The cloning strategy (Fig.18C), developed after careful restriction analysis of the 
genetic constructs involved, consisted initially in the following steps: 
 
1a) the pGEM3Z/tou vector was digested with restriction endonucleases     
XbaI/KpnI to excise the complete tou E103G/F176T gene cluster (6,432 bp);  
 
 
2a) the pGEM T-easy/rrnO vector  (Fig. 18A) was digested with the enzymes 
SphI/XbaI to  excise the rrnO promoter (600 bp); 
 
3a) the integration vector Pr19 was digested with the enzymes SphI/KpnI (3,800 
bp). 
 
As underlined before, the aim was to excise the tou gene cluster and the rrnO 
promoter from their original vectors and to insert these fragments into plasmid Pr19 
which was intended to be used for the integration of both promoter and the tou gene 
cluster in B. subtilis genome. To this purpose, 2μg of each purified plasmidic DNA 
were incubated at 37°C for 2h with 20 U of each enzyme in the presence of the 
appropriate buffer. The products of digestion were run on a 1% agarose gel, and the 
bands of interest were excised and purified as described in the Materials and 
Methods section.  
Afterwards, a two-step, three fragments-ligation was performed as follows:  
 
1b) the tou gene cluster digested with XbaI/KpnI (1a) and the rrnO promoter  
digested with SphI/XbaI (2a) were ligated;  
 
2b) the product derived from reaction 1b) was ligated with Pr19 vector digested 
with the enzymes SphI/KpnI (3a).  
 
Ligation 1b) was performed by mixing 30 ng of purified rrnO promoter and 400 ng of 
tou gene cluster. 10 μL of 2x “fast ligation buffer” (Promega) and 1 μL of 10 mM ATP 
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were added and the reaction mix was brought to a final volume of 17 μL with ddH2O. 
The sample was incubated at 42°C for 10 minutes, at RT for additional 10 minutes 
and then 1 μL of T4-ligase (3U/μl) was added.  
The reaction was incubated for 30 minutes at RT and then 2 μL of purified Pr19 
vector (60 ng) were added to the reaction mixture together with 1 μL of T4-ligase 
(reaction 2b). Final volume of the ligation mix was of 20 μL. 
This reaction mixture was used to transform E. coli strain Top 10. Cells were plated 
on LB/amp agar plates and incubated at 37°C for 16 hours. 12 colonies were picked 
and analyzed for the presence of the recombinant plasmid Pr19 containing both the 
tou gene cluster and the rrnO promoter. The analysis was performed using a colony 
PCR procedure. Among the positive clones, two were selected. Their plasmids 
purified and used for a restriction analysis which confirmed the presence in the 
isolated recombinant Pr19 vectors of both the tou E103G/F176T gene cluster and the 
rrnO promoter. This plasmid will be indicated from now on as NIC11. 
In order to verify the expression of the ToMO complex from plasmid NIC11, analytical 
expression experiments were performed and analyzed by SDS-PAGE.  
To this purpose, E. coli JM109 cells were transformed with either plasmid NIC11 or 
pGEM3Z-E103G/F176T. As already mentioned above, promoter rrnO is constitutive, 
therefore no inducer was added for the expression of the recombinant protein. 
Instead, 0.2 mM Fe(NH4)2(SO4)2 was added to the growing culture when it reached 
an optical density of 0.7 OD600, to supply an additional exogenous source of iron for 
the correct assembly of the iron-containing catalytic center of recombinant ToMO. 
We decided to analyze the recombinant expression of plasmid NIC11 1.5 and 3 
hours after the addition of Fe(NH4)2(SO4)2. For the positive control, i.e plasmid 
pGEM3Z-E103G/F176T, it was instead necessary to add both 0.1 mM IPTG and 0.2 
mM Fe(NH4)2(SO4)2 when the cell culture reached an optical density of 0.7 OD600 to 
induce the heterologous expression of the ToMO system.  
After induction, cells were collected by centrifugation, resulting pellets were 
suspended in 50 mM MOPS pH 7.0 and disrupted by sonication (3 min effective: 30 
sec ON, 30 sec OFF ). Cell suspensions were centrifuged at 12,000 rpm for 10 min 
at 4°C; 0.126 OD of each cell extract were analyzed by SDS-PAGE (Fig.19). 
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Figure 18: The rrnO promoter is cloned in the pGEM–T Easy vector (A). 
The tou E103G/F176T gene cluster is cloned into pGEM-3Z vector (B) 
The cloning strategy (C). 
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Figure 19: Lane 1: purified ToMO catalytic complex. Subunits ToMOA (57.6 kDa), 
ToMOE (38.2 kDa) and ToMOB (9.84 kDa) of the ToMO hydroxylase subcomplex 
ToMOH are indicated by the arrows. 
Lane 2, 3 and 6: cell extracts of JM109 transformed with plasmid pGEM3Z-
E103G/F176T after 45 minutes, 3h and O/N after the addition of Fe(NH4)2(SO4)2. 
Subunits A, E and B of the ToMO hydroxylase complex are evident. 
Lane 4, 5 and 7 cell extracts of JM109 transformed with plasmid NIC11 after 45 
minutes 3h and O/N after induction. Subunits A, E and B of the ToMO hydroxylase 
complex are more evident at 3h and O/N. 
Lane 8: cell extracts of JM109 transformed with plasmid pGEM3Z after O/N induction. 
No bands relative to subunits A, E and B are evident. 
 
Subunits: 
  ToMOA 
  ToMOE 
 
 
   ToMOB 
 
 
1           2          3         4          5         6         7        8 
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As it is evident from the SDS-PAGE, the expression level of the ToMO complex in 
plasmid NIC11 is comparable to what obtained when using pGEM3Z-E103G/F176T. 
Moreover, E.coli cells expressing plasmid NIC11, both on solid and in liquid media, 
show the accumulation in the extracellular medium of a blue pigment, indigo, which is 
the result of the hydroxylation of cellular aromatic compounds by the active ToMO 
system. 
Once verified that plasmid NIC11 actively expressed recombinant ToMO variant 
E103G/F176T in E.coli, the plasmid was used to transform B. subtilis as described in 
Material and Methods. Transformed cells of B. subtilis were plated on selective 
LB/agar plates containing chloramphenicol (5g/mL) and incubated at 37°C O/N. A 
few clones of transformed B. subtilis were separately inoculated in 4 mL of LB 
containing cloramphenicol (5 μg/mL), from now on indicated as LB/chf, and incubated 
O/N at 37°C. The cell pellet obtained from each clone was then subjected to genomic 
DNA extraction as described in Material and Methods. 
To verify the integration of the tou gene cluster in the genome of B. subtilis different 
PCR reactions using not less than 1 μg of template genomic DNA were performed. 
Moreover, the oligonucleotides used, which amplify either a 1,000 or a 1,700 bp 
specific region of the touA gene, one of the six orfs of the tou gene cluster, were 
chosen for the high annealing temperature (60°C) that was intended to avoid non-
specific amplifications. 
The PCR program used was the following: 
a) 2 min of initial denaturation at 94°C 
b) 31 cycles of: 
 1 min of denaturation at 94°C; 
 1 min of annealing at 60°C; 
 1.5 min of synthesis at 72°C; 
c) 10 min of synthesis at 72°C. 
No amplification product was observed, thus indicating the absence of the integrated 
tou gene cluster in the genome of transformed B. subtilis clones. 
The lack of integration of the tou gene cluster in B.subtilis genome was also 
confirmed by discontinuous coupled enzymatic assays performed on crude extracts 
of transformed cells of B. subtilis. 
To this purpose, selected clones were separately inoculated in 12 mL of LB/chf and 
incubated O/N at 37°C. Cell cultures were then diluted to 0.1 OD600 in 250 mL of 
LB/chf and grown under constant shaking at 37°C. 60 mL were withdrawn from each 
growing culture at 1.5h, 3h and 16h after the addition of 0.2 mM Fe(NH4)2(SO4). Cell 
cultures were supplemented with iron at an optical density of 0.9 OD600 (the promoter 
rrnO is constitutive, so no inducer was added for the expression of the recombinant 
protein). At the time intervals indicated above, cells were collected by centrifugation 
and the resulting pellets were suspended in 50 mM Tris HCl pH 7.5 at an optical 
density of 20 OD600 and disrupted by sonication (10 min effective: 30 sec ON , 30 sec 
OFF). 
Cell suspensions were centrifuged for 20 min at 4oC at 12,000 rpm and the 
supernatants filtered through a 0.45 μm filter. 500 L of each sample were incubated 
for 30 minutes at RT in a final volume of 600 L of 0.1 M Tris-HCL pH7.5 containing 
1mM phenol and 500 M NADH. It is important to underline that in the ToMO system 
the presence of the substrate phenol triggers the concomitant electron transfer chain 
that shuttles the electrons from NADH to the active site, in subunit ToMOA. When 
handling crude extracts most of the intracellular NADH might be oxidized, thus an 
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external addition of NADH is needed to support the enzymatic activity of the ToMO 
system. 
Afterwards, 3U of catechol 2,3-dioxygenase (see Materials and Methods) were 
added in order to convert the catechol formed from the hydroxylation of phenol to 2-
hydroxymuconic semialdehyde, a product whose formation can be monitored at 410 
nm. Unfortunately, no product was observed even after longer times of incubation or 
increasing the concentration of the cell extract in the assay. 
 
3.2.3 Cloning of tou gene cluster: the use of the non-integrative plasmid pHT01. 
The destination vector pHT01 (Fig.20) was a kind gift of Dr. Isticato’s research group. 
Vector pHT01 allows for high-level expression of recombinant proteins within the 
cytoplasm and is based on the strong σA-dependent promoter preceding the groE 
operon of B. subtilis which has been converted into an efficiently controllable (IPTG-
inducible) promoter by addition of the lac operator. Whereas the background level of 
expression in pHT01 is very low in the absence of inducer, a 1,300 fold increase in 
the level of recombinant expression was detected using the bgaB reporter gene (84).  
Our cloning strategy is summarized in Fig.21 and involved the following steps: 
 
A. The pHT01 vector was digested with restriction enzyme KpnI, followed by 
"fill-in" in order to eliminate this unique restriction site. The plasmid 
obtained was named pHT01/KpnI-. 
 
B. The pGEM3Z plasmid was digested with restriction endonucleases 
XbaI/AatII  to isolate a fragment that contained the unique restriction site 
KpnI. 
 
C. The fragment obtained at step 2) was cloned into plasmid pHT01/KpnI- 
using restriction sites XbaI/AatII. The resulting plasmid was named PG5. 
 
D. The tou variant E103G/F176T was excised from its vector of origin ptou by 
digestion with enzymes XbaI/KpnI and cloned into plasmid PG5 using the 
same unique restriction sites.  
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Figure 20: Map of the pHT01 plasmid. 
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Figure 21: Schematic representation of steps C) and D) of the 
cloning strategy described in paragraph 2.3. 
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A. Digestion of plasmid pHT01 with the restriction enzyme KpnI and fill-in. 
 
Approximately 3 g of purified plasmid pHT01 were digested at 37° C for 4 h with 40 
U of enzyme KpnI (NEB) according to the following scheme: 
 
 
 
 
 
 
 
 
 
 
 
 
The linearized vector was run on a 1% agarose gel, excised and purified as 
described in Materials and Methods. 2g of linearized plasmid were used for the fill-
in procedure according to the following scheme. 
 
 
 
 
 
 
 
 
 
 
 
 
The reaction was allowed to proceed for 5 min at 37°C. 
The reaction catalyzed by T4 DNA polymerase was blocked by incubating the 
sample at 75° C for 10 min. The sample was purified and used in a ligation reaction 
according to the following scheme: 
 
 
 
 
 
 
 
 
 
 
 
The reaction mixture was incubated at 14°C O/N. 
The reaction mixture was used to transform E. coli strain Top 10. Cells were plated 
on LB/amp agar plates and incubated at 37°C for 16 hours. 6 clones were selected 
 Volume L 
Plasmid pHT01 (100 ng/L) 30 
10X Buffer 1 NEB 4 
BSA 100X 0.4 
KpnI (10 U/L) 4 
H2O 1.6 
Total Volume 40 
 Volume L 
Linearized pHT01 (100 ng/L) 20 
10X T4 DNA polymerase  Buffer Promega 5 
1.25 mM dNTP  8 
T4 DNA polymerase Promega (10 U/L) 0.5 
H2O 16.5 
Total Volume 50 
 Volume L 
Plasmid pHT01 linearized and  
 fill-in (30 ng/L) 
7 
Buffer T4 DNA ligase 10X Promega 1 
10 mM ATP  1 
T4 DNA ligase Promega (3 U/L) 1 
Total Volume 10 
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from the transformation plates, their plasmids isolated and subjected to analytical 
digestion to verify the absence of the recognition site of the enzyme KpnI following 
the fill-in procedure. One of the positive clones, named pHT01/KpnI-, was selected 
and used in subsequent cloning procedures. 
 
 
B. Extraction of a XbaI/AatII fragment, containing a unique KpnI restriction 
site, from pGEM3Z plasmid. 
 
2.8 g of plasmid pGEM3Z were digested with restriction enzymes XbaI and AatII to 
obtain a 515 bp fragment that contains a unique KpnI restriction site. The reaction 
scheme was as follows: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The sample was loaded on 1% agarose preparative gel. The 515 bp fragment was 
excised from the gel and purified. 
 
 
C. Insertion of the pGEM3Z-derived 515 bp fragment into pHT01/KpnI- 
 
Approximately 3 g of pHT01/KpnI-, prepared as described above (step A), were 
digested for 3 h at 37 ° C with restriction enzymes XbaI and AatII according to the 
following scheme: 
 
 
 
 
 
 
 
 
 
 
 
 
The sample was loaded on 1% agarose preparative gel. The linearized fragment 
(7,955 bp) was excised, purified and used in the ligation reaction summarized below. 
The ligation was incubated O/N at 4° C and the fragment:vector ratio used was of ca. 
5:1. 
 
 Volume L 
Plasmid pGEM3Z (100 ng/L) 28 
10X Buffer 4 NEB  4 
XbaI (20U/L) 2 
AatII (20U/L) 2 
10X BSA  4 
Total Volume 40 
 Volume L 
Plasmid pHT01/Kpn
-
 (100 ng/L) 28 
10X Buffer 4 NEB  4 
XbaI (20U/L) 2 
AatII (20U/L) 2 
10X BSA  4 
Total Volume 40 
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E. coli cells strain TOP10 were transformed with 1 and 9 L of the ligation mix, plated 
on LB-agar/amp and incubated O/N at 37°C. 6 clones were selected, their plasmid 
isolated and analyzed by restriction analysis. Among the positive clones containing 
the XbaI/AatII fragment correctly inserted into plasmid pHT01/KpnI-, one was 
selected and indicated as PG5.  
 
D. Cloning of tou gene cluster in plasmid PG5. 
 
2 g of pGEM3Z-E103G/F176T were digested with enzymes XbaI and KpnI, at 37°C 
for 3h to obtain a fragment containing the entire gene cluster encoding for the active 
ToMO complex. 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
The sample was loaded on a 1% agarose preparative gel and subjected to 
electrophoresis. The fragment (6,000 bp) was excised from the gel and purified. 2 g 
of plasmid PG5 were digested at 37° C for 3 h with XbaI and KpnI according to the 
following scheme: 
 
 
 
 
 
 
 Volume L 
Plasmid pHT01/KpnI
- 
digested with XbaI/AatII (100 ng/L) 1 
Frgment XbaI/AatII from  pGEM3Z (10 ng/L) 3 
10X Buffer T4 DNA ligase  Promega 1 
ATP 10 mM 1 
T4 DNA ligase Promega (3 U/L) 1 
H2O 3 
Total Volume 10 
 Volume L 
pGEM3Z-E103G/F176T (100 ng/L) 20 
10X Buffer 2 NEB  4 
XbaI (20U/L) 2 
KpnI (10U/L) 2 
10X BSA  4 
H2O 8 
Volume Totale 40 
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The sample was loaded on a 1% agarose preparative gel. The linearized vector 
(8,500 bp) was excised, purified and used in the ligation reaction. The ligation 
reaction was incubated O/N at 4° C and the fragment:vector ratio used was 2:1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
E. coli cells strain TOP10 were transformed with 1 and 9 L of the ligation mix, plated 
on LB-agar/amp and incubated O/N at 37°C. 6 clones were selected, their plasmid 
isolated and analyzed by PCR to identify clones bearing the tou mutated gene cluster 
correctly inserted in PG5 plasmid. This plasmid will be indicated from now on as 
pDAM10.  
In order to verify the expression of the ToMO complex cloned in the new plasmid 
pDAM10, analytical expression experiments were performed and analyzed by SDS-
PAGE. To this purpose, E. coli JM109 cells were transformed with either plasmid 
pDAM10, or PG5 or pGEM3Z-E103G/F176T. In all three cases, for the recombinant 
expression both 1 mM IPTG and 0.2 mM Fe(NH4)2(SO4)2 were added to the growing 
cultures when they reached an optical density of 0.7-0.8 OD600. Induction time 
intervals analyzed were of 45 minutes, 3 hours and O/N. 
Cell extracts were analyzed by SDS-PAGE (Fig. 22); the expression level of the 
ToMO complex cloned in plasmid pDAM10 was comparable to that obtained when 
using pGEM3Z-E103G/F176T vector. Moreover, continuous coupled enzymatic 
assays (see Materials and Methods) performed on whole recombinant JM109 cells 
expressing either one of the two different plasmids confirmed a comparable 
hydroxylating activity using phenol as substrate (data not shown). 
 
 
 
 
 
 Volume L 
Plasmid pG5 (100 ng/L) 20 
10X Buffer 2 NEB  4 
XbaI (20U/L) 2 
KpnI (10U/L) 2 
10X BSA  4 
H2O 8 
Total Volume 40 
 Volume in L 
Plasmid pG5
 
digerito XbaI/KpnI (50 ng/L) 2 
Fragment XbaI/KpnI contenente the gene cluster tou (25 ng/L) 5 
10X Buffer T4 DNA ligasi  Promega 1 
ATP 10 mM 1 
T4 DNA ligasi Promega (3 U/L) 1 
Total Volume 10 
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Figure 22: Lane 1 and 9: purified ToMO catalytic complex. Subunits 
ToMOA (57.6 kDa), ToMOE (38.2 kDa) and ToMOB (9.84 kDa) of the 
ToMO hydroxylase subcomplex are indicated with the arrows. 
Lane  2 and 8: cell extracts of JM109 transformed with plasmid  pG5, 
Lane 3-7: cell extracts of JM109 transformed with plasmid pDAM10 
after 45’,1,5 h and O/N after the addition of Fe(NH4)2(SO4)2 and IPTG. 
Subunits A, E and B of the ToMO hydroxylase complex are evident 
after O/N induction (lane 7). 
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Plasmid pDAM10 was then used to transform B. subtilis. Cells of B. subtilis were 
plated on selective LB/agar containing chloramphenicol (5 µg/ml) and incubated at 
37°C for 14 h. To verify the presence of the plasmid in the chloramphenicol-resistant 
colonies of B. subtilis selected on the transformation plate, a PCR reaction was set-
up in which total DNA obtained from the cell crude extract was used as template.  
Thus, selected colonies were picked from the LB agar plate, inoculated separately 
into 500 μL of LB/chf and incubated at 37oC up to saturation. Samples were 
centrifuged for 10 min at 4oC at 12,000 rpm. Pellets were resuspended in 50 μL of 
lysis buffer (1x Taq polymerase buffer, 3.25 mM MgCl2, 2% Tween 20, 0.1 mg/mL 
Proteinase K). Cell suspensions were incubated at 60° C for 45 min and then at 90°C 
for 10 min. 0.5 μL of each cell lysate were used as the template for a PCR reaction 
performed in a final volume of 10 μL. 
 
The PCR reaction mixture contained: 
 
 1x Taq polymerase buffer 
 3.25 mM MgCl2 
 0.21 mM  mix dNTP 
 1 μM Reverse Primer (touD down, specific for a region of the tou gene cluster) 
 1 μM Forward Primer (touF up, specific for a region of the tou gene cluster) 
 1 U Taq polymerase 
 
The amplification conditions used were as follows: 
1) 2 min at 94°C of initial denaturation  
2) 30 cycles of: 
o 1 min at 94°C 
o 1 min at 46°C 
o 3 min at 72°C + 0.5 extension for each cycle 
3)  final synthesis step of 10 min at 72°C. 
 
 
Among positive clones, two were selected, their plasmids purified and used for an 
additional restriction analysis (data not shown) which confirmed the presence of the 
pDAM10 plasmid in the isolated clone of B. subtilis.  
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After that, cell suspensions were diluted in 250 mL of LB/chf in the case of the 
recombinant clone or in 250 mL of LB without chloramphenicol for the wt 
microorganism.  
In order to verify the effective expression in B. subtilis of the ToMO recombinant 
system encoded by plasmid pDAM10, a colony of the recombinant clone was 
inoculated in 12 mL of LB/chf and incubated O/N at 37°C. Afterwards, the saturated 
culture was diluted to 0.1 OD600 in 250 mL (final volume) of LB/chf. The culture was 
supplemented with 1mM IPTG at an optical density of 0.7/0.8 OD600.  After 2h, 4h and 
6h cells were collected by centrifugation and pellets were suspended in 0.1 M Tris 
HCl pH 7.5. 
Both discontinuous assays on crude cell extracts (see paragraph 2.2) and continuous 
coupled assays were performed in the presence of purified catechol 2,3 dioxygenase 
and phenol as substrate, but no hydroxylating activity was observed (data not 
shown). 
 
3.2.4 Total RNA puriﬁcation and RT-PCR  
The lack of hydroxylating activity in the recombinant clones of B.subtilis transformed 
with plasmid pDAM10 might be either due to a transcriptional or to a translational 
problem. In this latter case a different codon usage might have been responsible for 
the absence of the ToMO active complex in the cell extract of transformed B. subtilis 
cells.  
Thus, we decided to verify the presence of the mRNA coding for the tou gene cluster 
by RT-PCR. To this purpose, cell pellets of 12 mL of O/N grown cultures of B. 
subtilis/pDAM10, E.coli/PG5 and E.coli/pGEM3Z-wt ToMO were collected. 
Total RNA was extracted with the TRI-Reagent kit (Sigma) and RT-PCR reactions 
were performed using the “Access RT-PCR System” kit (Promega) as described in 
Material and Methods section 2.15. 
Specific primers amplifying a 700 bp region in the touA orf were selected. As shown 
in Fig. 23, RT-PCR experiments yielded fragments of the expected length only when 
RNA was extracted from E.coli/pGEM3Z-wt ToMO. No ampliﬁcation was detected in 
the case of B. subtilis transformed with PG5. Little ampliﬁcation was observed in the 
case of B.subtilis transformed with pDAM10. However a band of the same intensity 
and apparent length was observed in the control reaction performed in the absence 
of reverse transcriptase. This indicates the residual presence in the sample of 
plasmidic DNA despite the DNaseI treatment that had been performed on all samples 
analyzed in this experiment (Materials and Methods). 
In conclusion, this experiment would indicate that the ToMO system was not 
expressed in our transformed B.subtilis clones due to a transcriptional problem. 
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Figure 23: Analysis on 1% agarose gel of the RT-PCR ampliﬁcation products obtained using 
oligonucleotides specific for a 700 bp region of the touA orf. Lane 1: 2-log ladder (New 
England Biolabs). Lane 2: ampliﬁcation products obtained using as template total RNA 
extracted from E.coli transformed with pGEM3Z/wtToMO. Lane 3: ampliﬁcation products 
obtained using as template total RNA extracted from B. subtilis transformed with pDAM10. 
Lane 4: ampliﬁcation products obtained using as template total RNA extracted from E.coli 
transformed with plasmid PG5. Lane 5, 6 and 7 are negative controls, namely RT-PCR 
reactions carried out in the absence of reverse transcriptase. 
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3.3.1. 3,6 diketocamphane 1,6-monooxygenase, a type II Baeyer-Villiger 
Monooxygenases from Pseudomonas putida NCIMB 10007. 
BVMOs can be classified into two distinct groups (85). Type I BVMOs contain flavin 
adenine dinucleotide (FAD) as the co-factor and use NADPH as the source of 
electrons (86). These enzymes contain two Rossmann sequence motifs, GxGxxG, 
suggesting that they bind the two cofactors (FAD and NADPH) using separate 
dinucleotide binding domains. Type II BVMOs use FMN as flavin cofactor and NADH 
as electron donor and are composed of two different subunits that occur in a 
quaternary structure of the type  ( 86,87).  
Since their discovery, much research has been performed to explore the biocatalytic 
properties of BVMOs, either using whole-cells or isolated enzymes. However, 
whereas most of the enzymes characterized so far refer to type I BVMOs (88), only a 
few examples for FMN/NADH-containing type II BVMOs have been investigated. A 
reason might be the challenging overexpression of these enzymes in a heterologous 
host since, in contrast to type I BVMOs, the oxygenating and dehydrogenase 
subunits are distinct proteins. Type II BVMOs are of special interest for industrial 
applications because -among others- of the lower costs of NADH compared to 
NADPH, but hold more challenges regarding the structural feature because the 
oxygenase and FMN reductase subunits are distinct polypeptide chains forming only 
a loose complex. 
Pseudomonas putida NCIMB 10007 is able to grow on camphor as unique carbon 
and energy source. Camphor exists in two enantiomeric forms; the (+)- isomer occurs 
primarily in the wood of Cinnanocum camphora and, although the (-)-isomer is less 
widely distributed, it occurs in a number of plant essential oils. Three different 
Baeyer-Villiger monooxygenases (BVMOs) were reported to be involved in the 
camphor metabolism of Pseudomonas putida NCIMB 10007. After initial 
hydroxylation of (+)-camphor by a P450 monooxygenase and oxidation by a 
dehydrogenase, the resulting 2,5-diketocamphane is degraded by 2,5-
diketocamphane monooxygenase (2,5-DKCMO). The corresponding enzyme for the 
decomposition of the (-)-isomer, namely 3,6-diketocamphane 1,6-monooxygenase 
(3,6-DKCMO), was first reported in 1965 (Conrad et al. 1965) (Fig. 24). 
The aim of this part of my PhD project, carried out in the laboratory of Prof. Littlechild 
at the University of Exeter, was to i) optimize the heterologous expression and the 
purification of 3,6 DKCMO in E.coli, and crystallize the protein, ii) clone and express 
the flavin reductase component of 3,6 DKCMO, and iii) co-crystallize the oxygenase 
and the reductase components of the 3,6 DKCMO. 
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Figure 24: Degradation of (+)- and (-)- camphor isomers by 
Pseudomonas putida NCIMB 10007. “Fred” is the acronym for the 
flavin reductase. 
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3.3.2. Expression and purification of 3,6-diketocamphane 1,6 monooxygenase 
(3,6 DKCMO).  
Transformation of E. coli strain BL21(DE3) with pET-28_3,6-DKCMO, a plasmid 
bearing the gene encoding for the oxygenase component of 3,6-DKCMO and a N-
terminal His-tag, was carried out as described in the Material and Methods section. 
The construction of this plasmid has been reported elsewhere (89). 
For soluble expression of recombinant 3,6-DKCMO, co-expression of chaperones 
GroES and GroEL was necessary (89). To this purpose, BL21(DE3) cells were co-
transformed with both the pET-28_3,6-DKCMO plasmid and Pgro7(TaKara 
Chaperone Plasmid Set), an arabinose-inducible plasmid designed to express groES 
and groEL proteins that function together as a "chaperone team" to enable optimal 
protein expression and folding in heterologous hosts. 
An O/N preinoculum of fresh transformed BL21(DE3) cells was grown at 37°C, under 
constant shaking, in 5 mL of sterile TB containing kanamicin (50 g/mL, for the 
selection of pET-28_3,6-DKCMO) and chloramphenicol (50 g/mL, for the selection 
of Pgro7). From now on the presence of both antibiotics in the growth medium at 
these concentrations will be referred to as “kan/chf“. After 14 hours, the saturated 
preinoculum was diluted in 250 mL of fresh sterile TB (kan/chf) in a 1L-Erlenmeyer 
flask and was allowed to grow under constant shaking at 37°C up to 0.6 OD600.  
Afterwards, 10 mL of this cell culture were diluted 100 fold in 1L of fresh sterile TB  
(kan/chf) in a 2L-Erlenmeyer flask and allowed to grow at 37°C at 200 rpm. 
Expression of the recombinant GroES-GroEL system was induced by adding to the 
growing culture 2 mg/mL of l-arabinose at an optical density of 0.5 OD600. After 30 
minutes the recombinant expression of 3,6-DKCMO was induced by adding IPTG to 
a final concentration of 0.1 mM. To improve protein solubility, the growth temperature 
was shifted from 37°C to 20°C. The induced cell culture was allowed to grow under 
these conditions for 16 hours.  
Cells were harvested by centrifugation and resuspended in a buffer containing 
20 mM K2HPO4, 0.1 mM EDTA, 6 mM -mercaptoethanol, 0.01 mM PMSF, at 
pH 7.5. Cell disruption was performed by a single passage through a French press.  
After centrifugation of the cell suspension for 45 min at 10,000×g, the soluble fraction 
was purified by affinity chromatography via the N-terminal His-tag on an automated 
Äkta purifier system. To this purpose, 1 mL of HisTrap FF resin with bound Ni2+ was 
equilibrated with buffer A (100 mM K2HPO4, 300 mM NaCl, pH 7.5) supplemented 
with 30 mM imidazole. After loading, the column was washed with three volumes of 
buffer A (100 mM, 300 mM NaCl, pH 7.5) supplemented with 30 mM imidazole 
followed by two volumes of buffer A supplemented with 60 mM imidazole to remove 
unspecific bound proteins. Elution was performed by adding three volumes of buffer 
A supplemented with 1 M imidazole. Protein fractions were analyzed via online 
absorption measurement at =280 nm; aliquots of peak fractions were loaded on a 
SDS-PAGE (Fig.25-A). SDS-PAGE analysis confirmed the presence of a major band 
at approximately 40 kDa, which corresponds to the theoretical estimated molecular 
weight of 44.5 kDa of the His-tagged protein. 3,6-DKCMO-containing fractions were 
yellowish, and their UV-vis spectrum suggested the presence of a bound FMN 
cofactor (data not shown). 
Most relevant fractions were pooled and, in order to remove imidazole from the 
sample, were loaded into a 60 mL size exclusion desalting column (Sephadex G25 
matrix), equilibrated with 50 mM Tris-HCl pH 7.5/100 mM NaCl. Protein fractions 
were again analyzed via online absorption measurement at 280 nm, loaded on a 
SDS-PAGE (Fig.25-B) and pooled. SDS-PAGE analysis showed that the purity of the 
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protein sample obtained was suitable for crystallization experiments. In this case, 
however, 3,6-DKCMO-containing fractions were colorless, which confirmed previous 
studies in which FMN was reported not to be covalently bound to the enzyme and 
easily lost during purification procedures. 
Determination of protein concentration of all samples described so far (cell extract, 
purified sample, desalted sample) was carried out with the BCA kit and a standard 
curve of BSA in the same buffer in a range of 2–0.005 mg/ml was used. Samples 
were measured in triplicates in three different dilutions. 
The purified protein sample was then concentrated using Vivaspin Centrifugal 
concentrator tubes to obtain a final concentration of 10 mg/ml for crystallization 
studies.  
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Figure 25: 
A)  lane 1: Pageruler prestained molecular weight  standard 10-170 kDa (Pierce);  
lanes 2-8: aliquots of peak fractions eluting from the affinity chromatography.  
B) lane 1: Pageruler prestained molecular weight standard 10-170 kDa (Pierce);  
lanes 2-9: aliquots of peak fractions eluting from the Sephadex G25;  
lane 10: Molecular weight standard (40 kDa). 
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3.3.3 Crystallization of 3,6-diketocamphane 1,6 monooxygenase (3,6 DKCMO). 
The main aim of any enzyme study is the resolution of the protein structure. 
Structural information helps understanding the conformational and functional details 
of the biocatalytic mechanism. Successful purification and crystallization of protein is 
essential to extract appropriate X-ray diffraction data which can lead to resolution of 
the protein structure.  
Crystallization studies were carried out with purified 3,6-DKCMO prepared as 
described in paragraph 3.2. A protein concentration in the range 7-10 mg/mL was 
used in all experiments of crystallization. The protein solution used for crystallization 
contained also 5 mM FMN, 0.2 mM NADH, 0.2 M (-)- Camphor, which are, 
respectively, the cofactors and the substrate used by 3,6-DKCMO. This addition was 
performed to try to obtain crystals of 3,6-DKCMO with these molecules bound, which 
might give more details on the catalytic mechanism of this enzyme. Samples were 
always incubated 3h at RT before starting the crystallization experiments. Crystal 
screenings were set up in micro-batch trials in JCSG-plusTM HT-96 wells plate using 
Oryx 6 robot (Douglas Instruments, Fig.26-A). JCSG-plus HT-96 is a 96 reagent 
deep-well block, optimized sparse-matrix screen of classic and modern conditions, 
devised at the Joint Centre for Structural Genomics and developed further by 
Newman and Perrakis at the Netherlands Cancer Institute. The robot was set up to 
dispense 1:1 mixture of Protein:Screen condition in each well (Fig.26-B). The volume 
of the dispensed droplet was 1 L. The resultant plates were covered with Al’s oil (a 
50:50 mixture of silicon oil:paraffin oil) and stored at 20°C.  Appearance and growth 
of crystals was monitored over every three days.  
The best crystals were obtained in the presence of PEG as precipitant and were 
distinctly needle-like or fibrous in shape. The largest and the best-looking crystals 
were thin-rod needles (Fig. 27). 
A selection of 3,6-DKCMO crystals were flash-frozen. The crystals were frozen in a 
vial immersed in liquid nitrogen until they were analyzed at the Diamond Light Source 
UK national synchrotron. Prior to freezing, a cryoprotectant (PEG 400 or 30% 
glycerol) was added to the crystal. The cryoprotectant solution consisted, in addition 
to the cryoprotectant itself, in an adjusted mixture of the original crystallization 
reagents with an additional precipitant when required. A total of 30 crystals were 
frozen. 
These crystals diffracted to beyond 2 Å resolution, allowing a complete data set to be 
collected to 2.5 A resolution at 100 K. The space group was identified as P212121, 
with unit-cell dimensions a = 54.6, b = 93.2 and c = 154.1 A . 
The crystals of 3,6-DKCMO obtained under the conditions reported above diffracted 
but FMN was mainly found in solution in the droplet. Moreover the crystal diffraction 
pattern clearly showed that residual FMN present in the crystal was external to the 
protein structure (data not shown). As a consequence, the crystallization experiment 
was repeated by increasing the concentration of FMN up to 20 mM and in the 
presence of all other components (substrate and NADH), whose concentration was 
kept identical compared to the previous experiment. Also in this case it was not 
possible to recover any FMN correctly inserted in the binding site. 
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Figure 26:  
A)  An image of Oryx 6 robot (Douglas Instruments); 
B) A close-up of the robotic arm of the Oryx 6 robot (Douglas Instruments).  
A B 
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Figure 27: Crystals of the oxygenase component 
of 3,6-diketocamphane monooxygenase. 
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Data are currently under investigation. However, the lack of FMN in the crystal 
structure of 3,6-DKCMO undoubtedly limits the detailed understanding of the catalytic 
mechanism and needs further investigation. 
However, it could be hypothesized that the His-tag could interfere with crystal growth 
and X-ray diffraction studies. Therefore, with the aim of improving the incorporation of 
FMN inside the 3,6-DKCMO, to improve the quality of crystals and obtain better 
structure refinement, the His-tag could be cleaved off before undertaking 
crystallisation work, or the protein could be purified using a different purification 
methodology using a non-His tagged protein. 
 
 
3.3.4 ThermoFluor Assay on 3,6-DKCMO. 
ThermoFluor  assay is a miniaturized high-throughput protein stability assay that can 
be used to analyze the relationship between protein thermal stability and ligand 
binding. Binding ligands generally increase protein thermal stability by an amount 
that is proportional to the concentration and affinity of the ligand. Binding constants 
(Kb) are measured by examining the systematic effect of ligand concentration on 
protein stability. The effects of ligand binding depend on the thermodynamics of 
protein stability and in particular on the unfolding enthalpy. It is important to underline 
that an extension of current theoretical treatments has been recently developed for 
tight binding inhibitors, where ligand effect on Tm  can also reveal binding 
stoichiometry. In the typical experimental set-up, a fluorescent dye such as SYPRO 
orange is used. This latter is a solvatochromic dye used as an indicator of protein 
unfolding that has a low-fluorescence quantum yield in water. Partitioning of the dye 
into melted protein results in a significant increase in fluorescence (Fig.28) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 28: Schematic representation of the ThermoFluor binding assay.  
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The samples used for the ThermoFluor binding assay contained, in a final volume of  
(Fig. 28): 
- 7 mg of 3,6 DKCMO (blue trace); 
- 30 mM FMN (red trace); 
- 7 mg of 3,6 DKCMO, 20 mM FMN, 0.2 mM NADH, 0.2 M (-)- camphor (yellow 
trace); 
- 7 mg of 3,6 DKCMO, 30 mM FMN, 0.2 mM NADH, 0.2 M (-)- camphor (green 
trace). 
Preliminary results showed that an increase of Tm was obtained in the samples 
containing the cofactors and the substrate (trace yellow and green). Moreover, this 
temperature shift (ΔTm) was proportional to the FMN concentration in the sample.  
Data are still under investigation, and further experiments are needed in order to 
investigate the possible role of NADH and camphor on the ΔTm . 
 
 
 
 
 
 
 
 
 
 
 
 7 mg 3,6 DKCMO            Tm 45 
 30 mM FMN                     Tm 46 
 20 mM FMN/NADH/CAM Tm 50 
 30 mM FMN/NADH/CAM Tm 53 
 
 
 
Figure 28: ThermoFluor binding assay.  
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Flavin reductase (CAM PLASMID) Pseudomonas putida 
ATGACTAAAGTCGCCGCAGAGATAGTACGAAGCGCTATCGACCCACAATGGTTCAGAGCTGTTCTGGGTC 
AGTATCCCACTGGCGTATGCGCCGTTACCGCGATGGATCCGGACGGCAAGATGTCGGGTATGGCGGTAGG 
TTCTTTCACCTCGGTTTCGCTGAATCCGCCGTTGGTGGCCTTTCTGCCGGATCGCAGCTCAACGAGTTGG 
CCGAAAATCGAGCGCGCCGGCAAGTTCTGCGTCAACGTGTTGAGTGATCAGCAACTGGGAGTTTGTAAGC 
GTTTTGCCTCCAAGGACGAAGACAAGTTTTCCGGGCTGGTATATCGCCTCTCCGACAACGGTTCACCGAT 
CATCGAGGGCGTCGTAGCCTGGATCGATTGTGACCTGCATTCGGTTCAGGAGGCGGGGGATCACTATATC 
GTCATTGGCTCTGTACGTGAATTGCAGGTCGAGTCCGAGGATTCCGCACTGCTTTTCTATCGGGGTGGTT 
ATGGTGGCTTTGCCGCTATCTGA 
 
3.3.5 Cloning, expression and purification of the flavin reductase component of 
3,6-DKCMO. 
As already underlined in paragraph 3.1, 3,6-DKCMO consists of a homodimeric 
FMN-containing oxygenase and a second component that has been referred to as a 
NADH dehydrogenase or NADH oxidase. This latter has not been expressed as a 
recombinant protein and characterized yet, thus leading to a fundamental lack of 
information on the catalytic relationship between the oxygenase and the reductase 
components present in the 2 quaternary complex of 3,6-DKCMO. 
Amplification of the Flavin Reductase encoding gene (from now on referred to as 
FRED, Fig. 29) was performed by using the CAM-plasmid as template (88).  
 
 
 
 
 
 
 
After initial denaturation for 30’s at 98 °C,  the primers annealing was performed for 
30 s at 60 °C; the elongation step was performed at 72 °C for 1 min. This sequence 
was repeated for 34 cycles. The final elongation step was allowed to proceed for 
10 min at 72 °C.  
The degenerate primers used for amplification were designed to insert restriction 
sites for EcoRI at the N-terminus and NotI at the C-terminus (EcoRI_G1_fw: 5′-
GAATTCATGACTAAAGTCGCCGCAGA-3′;NotI_G2_rv:5′-GCGGCCGCTCAGATAG 
CGGCAAAGCC-3′). 
The resulting amplified 550 bp fragment was directly ligated into plasmid 
pJET1.2/blunt. This latter is a linearized cloning vector, which accepts inserts from 6 
bp to 10 kb. The 5'-ends of the vector cloning site contain phosphoryl groups, 
therefore, phosphorylation of the PCR primers was not required. Recircularized 
pJET1.2/blunt vector expresses a lethal restriction enzyme after transformation and 
is not propagated. As a result, only recombinant clones containing the insert appear 
on culture plates.  
The ligation reaction was performed by using a fragment:vector molar ratio of 3:1 and   
was incubated at room temperature for 5 min. The ligation mixture was used to 
transform competent cells of E. coli strain BL21(DE3). Cells were then plated on 
LB/amp agar plates and incubated at 37°C for 16 hours. 
Figure 29: Flavin Reductase sequence 
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11 colonies were picked and analyzed for the presence of the recombinant plasmid 
pJET 1.2/blunt containing the FRED gene. The presence of the gene correctly cloned 
in this vector was verified by restriction analysis with NotI and EcoRI endonucleases. 
The FRED gene was excised from pJET1.2/blunt vector by digesting with NotI 
and EcoRI endonucleases and ligated into vector pET-28b digested with the same 
enzymes. Ligation  was performed under the same conditions described above. 
This reaction mixture was used to transform E. coli strain BL21(DE3). Cells were 
plated on LB/amp agar plates and incubated at 37°C for 16 hours. 3 colonies were 
picked, their plasmids purified and used for a restriction analysis which confirmed the 
presence in the isolated clones of the recombinant pET-28b vector with the FRED 
gene correctly inserted. The resulting plasmid was called pET-28_FRED.  
For the recombinant expression of the protein encoded by the FRED gene, a O/N 
preinoculum of transformed BL21(DE3) cells was grown at 37°C, under constant 
shaking, in 5 mL of sterile TB containing kanamicin (50 g/mL). After 14 hours, the 
saturated preinoculum was diluted in 250 mL of fresh sterile TB (kan) in a 1L-
Erlenmeyer flask and was allowed to grow under constant shaking at 37°C up to 0.6 
OD600.  Afterwards,  10 mL of this cell culture were diluted 100 fold in 1L of fresh 
sterile TB  (kan) in a 2L-Erlenmeyer flask and allowed to grow at 37°C at 200 rpm. 
At an optical density of 0.7/0.8 OD600 recombinant expression of FRED was induced 
by adding IPTG to a final concentration of 0.1 mM. To improve protein solubility, the 
growth temperature was shifted from 37°C to 20°C .The induced cell culture was 
allowed to grow under these conditions for additional 16 hours.  
Cells were harvested by centrifugation and resuspended  in a buffer containing 
20 mM K2HPO4, 0.1 mM EDTA, 6 mM -mercaptoethanol, 0.01 mM PMSF, at 
pH 7.5. Cell disruption was performed by a single passage through a French press.  
After centrifugation of the cell suspension for 45 min at 10,000×g, the soluble fraction 
was purified by affinity chromatography via N-terminal His-tag on an automated Äkta 
purifier system. The optimized experimental conditions found for the elution of the 
protein are the same as those reported in paragraph 3.2 for the oxygenase 
component of 3,6-DKCMO. 
Protein fractions were analyzed via online absorption measurement at =280 nm; 
aliquots of peak fractions  were loaded on a SDS-PAGE (Fig.30).  
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As it is evident from the SDS-PAGE analysis a protein band with an apparent 
molecular weight of 18 kDa is present in the peak fractions. However, the protein was 
heavily contaminated with other proteins. Therefore the affinity chromatography was 
repeated by using an imidazole gradient consisting of the following steps:  5%; 10%; 
15; 20%; 30% and 50% imidazole. The protein eluted at a concentration of imidazole 
in the range 10%-15% and the SDS-PAGE analysis showed a sample whose purity 
was undoubtedly higher than the previous attempt. 
Most relevant fractions were pooled and, in order to remove imidazole from the 
sample, were loaded onto a 60 mL size exclusion desalting column (Sephadex G25 
matrix), which was equilibrated with 50 mM Tris-HCl pH 7.5/100 mM NaCl. Protein 
fractions were again analyzed via online absorption measurement at 280 nm, loaded 
on a SDS-PAGE and pooled. SDS-PAGE analysis showed that the purity of the 
protein sample obtained is very high and suitable for crystallization experiments and 
activity assays (data not shown).  
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Figure 30:  
A) lane 1: Pageruler prestained molecular weight standard 10-170 kDa (Pierce); lanes 2-7: 
aliquots of peak fractions eluting from the affinity chromatography.  
B) lane 1: Pageruler prestained molecular weight standard 10-170 kDa (Pierce); lanes 2-7 
aliquots of peak fractions eluting from affinity chromatography with a concentration of 
imidazole in the range 10%-15%. 
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In conclusion, the expression and purification of recombinant FRED have been 
optimized and the availability of the purified protein will allow to carry out in the near 
future activity studies with the two protein both individually (3,6 DKMCO and FRED) 
and as a complex. Moreover, co-crystallization attempts will be performed to gain 
further insight into their conformational dynamics and their ability to distinguish 
enantiomerically specific camphor molecules. With a detailed account of the 
structure, substrate specificity and mechanism, the purified enzymes can be 
modulated to aid large scale production of useful drug intermediates. 
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In this PhD thesis the use of oxygenase activities for the biosynthesis of novel 
aromatic antioxidants has been investigated, in the more general framework of the 
“oxyfunctionalization” of aromatic compounds and its effective use for industrial 
processes. Main aims were i) to validate the use of the ToMO system for the 
production of novel antioxidants starting from non-natural substrates; ii) to verify the 
possibility of expressing recombinant ToMO in a GRAS microorganism such as B. 
subtilis; iii) to express and purify the oxygenase and the flavin reductase components 
of the 3,6 diketocamphane 1,6 monooxygenase (3,6 DKCMO) from Pseudomonas 
putida NCIMB 10007.  
 
During this PhD project six novel hydroxylated compounds were obtained through the 
bioconversion of non-natural substrates using the ToMO multicomponent 
monooxygenase from P. sp. OX1, thus confirming the versatility of this enzyme in 
catalyzing hydroxylation reactions on a wide array of monocyclic aromatic molecules. 
Interestingly, we found that not all these novel hydroxylated compounds were able to 
reduce the DPPH stable radical, a common test system for determining the 
scavenging properties of putative antioxidants. In fact, phenols such as those 
produced from the hydroxylation of 2-phenoxyethanol characterized by the fact that 
an oxygen atom, different from the one derived from the hydroxyl group added by the 
enzyme, is directly bound to the aromatic ring (Fig.8 of the Introduction section), were 
“responsive” to this assay. On the other hand, phenols derived from both phthalan 
and 2-indanol, molecules in which no other oxygen atom is directly bound to the 
aromatic ring (Fig.8 of the Introduction section), and from 2-phenylethanol (Fig.5), 
were not able to reduce the DPPH radical. Otherwise, only catechols, such as 
hydroxytyrosol – always used in our experiments as a reference compound- and the 
dihydroxylated derivative of 2-indanol gave a positive response in this experiment. 
Noteworthy, all the compounds share a common, although differential, antioxidant 
effect on eukaryotic cells of the H9c2 cell line subjected to a mild oxidative stress 
induced by sodium arsenite. The discrepancy between the in vitro and the ex vivo 
assays showed from one side a possible limitation in the use of the DPPH assay as 
the unique methodology to assess the in vitro antioxidant potential of novel 
compounds, and on the other hand might suggest that the antioxidant effect 
observed in cells might not be due to a simple scavenge of ROS based on the 
chemical mechanisms briefly described in the Introduction (paragraph 1.2), but it 
might be dependent on other molecular events that have not been elucidated yet. 
In the near future, the antioxidant potential of our novel hydroxylated compounds has 
to be analyzed more in detail using for example other eukaryotic cell lines and 
inducing the oxidative stress also with other agents, such as H2O2, that might be 
considered the more common physiological source of ROS. Moreover, the availability 
of the molecules produced under the present study opens new possibilities for 
obtaining new antioxidant molecules. In fact, they can be now functionalized, to 
modify their biological activity, by using different approaches such as (i) the use of 
the hypervalent iodine reagents IBX (2-Iodoxybenzoic acid) to obtain thiolic and 
selenolic derivates that might show improved antioxidant properties both in vitro and 
in vivo; and/or the use of glycosydases to produce glycosidic derivatives. Indeed, it 
has been frequently reported that glycosylation strongly affects both the stability and 
the hydrophility of target molecules thus modifying their bioavailability and their in 
vivo effect. 
All the data collected will also have important implications for the rational design of 
multipotent antioxidants based on aromatic nuclei that, for their chemical versatility, 
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are ideal candidates to create molecules with multiple pharmacological effects. 
Phenols and catechols are in fact promising starting points to merge with other 
pharmacophores thus obtaining  multipotent agents with antioxidant effects and 
beyond. 
 
The effective biotechnological use of the ToMO system and its variants is strongly 
dependent on the stable integration of the gene encoding this enzyme either in the 
genome or in plasmids whose selection is not dependent on the presence of 
antibiotics, of a GRAS microorganism. The expression of ToMO in a heterologous 
host different from E.coli and compatible with a future scale-up of bioprocesses 
based on the use of this enzymatic activity was only partially successful. We were 
able to clone the tou gene cluster into a suitable shuttle vector and to express the 
functional multicomponent system in strain JM109 of E.coli. The presence of the 
novel plasmid was assessed in B. subtilis after transformation of competent cells. 
However, no recombinant expression was detected. RT-PCR experiments suggested 
that this was due to the lack of the corresponding mRNA. This result prompts our 
interest in trying to insert the recombinant pDAM10 plasmid in different strains of B. 
subtilis, as the lack of transcription could be related to a scarce recognition from 
endogenous RNA polymerases of the promoter region present in our genetic 
construct, that was instead correctly transcribed in E. coli. In a parallel approach 
other shuttle vectors for B.subtilis will also be used for the cloning of the complete tou 
gene cluster as our experiments cannot exclude that the lack of mRNA might be due 
to an intrinsic incompatibility between our plasmid and the host strain used. 
Moreover, the use in the near future of other GRAS microorganisms for the scale-up 
of ToMO-catalyzed biosynthesis such as Kluyveromyces lactis, or Lactobacillus casei 
will be attempted. 
 
Bacterial Multicomponent Monooxygenases such as the ToMO system are not the 
only enzymatic tool which have a great biotechnological potential for the 
functionalization of aromatic compounds to produce high-added value molecules. 
Great attention, in fact, has been devoted in the last decades to the Baeyer–Villiger 
Monooxygenases (BVMOs). During my experience at the Laboratory of Prof. Jennifer 
Littlechild at the Exeter Biocatalysis Centre (College of Life and Environmental 
Sciences at the University of Exeter, UK) the recombinant expression and purification 
of the oxygenase and flavin reductase component of 3,6 DKCMO from Ps. putida 
NCIMB 10007 were optimized. This allowed obtaining suitable amounts of both these 
proteins to set-up several successful experiments of crystallization. The data 
collected from crystal analysis are still under investigation. The determination of the 
three-dimensional structure of these proteins, both individually and in complex with 
their substrate, will give important clues for the future site-directed mutagenesis of 
this BVMO, a mandatory step to effectively evaluate the versatility of this enzymatic 
complex in catalyzing the conversion of non-natural substrates of industrial interest.  
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Biocatalysis is today a standard technology for the industrial production of several chemicals, and the
number of biotransformation processes running on a commercial scale is constantly increasing. Among
biocatalysts, bacterial multicomponent monooxygenases (BMMs), a diverse group of nonheme diiron enzymes
that activate dioxygen, are of primary interest due to their ability to catalyze a variety of complex oxidations,
including reactions of mono- and dihydroxylation of phenolic compounds. In recent years, both directed
evolution and rational design have been successfully used to identify the molecular determinants responsible
for BMM regioselectivity and to improve their activity toward natural and nonnatural substrates. Toluene
o-xylene monooxygenase (ToMO) is a BMM isolated from Pseudomonas sp. strain OX1 which hydroxylates a
wide spectrum of aromatic compounds. In this work we investigate the use of recombinant ToMO for the
biosynthesis in recombinant cells of Escherichia coli strain JM109 of 4-hydroxyphenylethanol (tyrosol), an
antioxidant present in olive oil, from 2-phenylethanol, a cheap and commercially available substrate. We
initially found that wild-type ToMO is unable to convert 2-phenylethanol to tyrosol. This was explained by
using a computational model which analyzed the interactions between ToMO active-site residues and the
substrate. We found that residue F176 is the major steric hindrance for the correct positioning of the reaction
intermediate leading to tyrosol production into the active site of the enzyme. Several mutants were designed
and prepared, and we found that the combination of different mutations at position F176 with mutation E103G
allows ToMO to convert up to 50% of 2-phenylethanol into tyrosol in 2 h.
Reactions in which organic compounds are oxygenated or
hydroxylated are of great value for organic synthesis (33).
However, selective oxyfunctionalization of organic substrates
can be a significant problem in organic synthesis, as these
reactions are often carried out with strong oxidizing agents and
occur with little chemo-, regio-, and enantioselectivity (33, 50).
Therefore, growing attention has been dedicated in the last
years to the development of biotransformations which make
use of the metabolic versatility of either purified enzymes or
whole microorganisms to perform oxyfunctionalization of or-
ganic substrates of industrial interest (1, 7, 10, 21, 50). These
methodologies, compared with established chemical processes,
are appealing alternatives as means to obtain active aromatic
compounds under mild experimental conditions and without
employing toxic reagents (20, 26, 48).
Bacterial multicomponent monooxygenases (BMMs) allow
the preparation of several aromatic active compounds with
high regioselectivity and stereoselectivity (23, 41, 50). BMMs
form a diverse group of nonheme diiron enzymes that activate
dioxygen, thus facilitating oxygen atom transfer to specific or-
ganic substrates (32, 46), and perform a key metabolic function
in promoting catabolic and detoxification reactions (55). These
enzymes catalyze a variety of complex oxidations, including
mono- and dihydroxylation of aromatic compounds (40, 55).
BMMs usually consist of a 200- to 250-kDa dimeric hydroxy-
lase component organized in a ()2 quaternary arrange-
ment, a 10- to 16-kDa regulatory protein that enhances the
catalytic turnover (3), and a FAD- and (2Fe-2S)-containing
reductase that mediates the electron transfer from NADH to
the active site of the hydroxylase (31, 38). An additional Rieske
protein may be present to assist the electron transfer between
the reductase and hydroxylase components. The hydroxylation
chemistry takes place at a nonheme carboxylate-bridged diiron
center, harbored in the active site of the hydroxylase moiety,
coordinated by four glutamate and two histidine residues from
a four-helix bundle (32, 35, 36, 38).
Oxygenase biocatalysts are already used in the chemical in-
dustry to obtain additives for agriculture, synthones, drugs, and
plastics (7), and due to their catalytic properties, these multi-
component enzymes, either wild type (wt) or engineered, are a
versatile biosynthetic tool for the preparation of different ac-
tive aromatic compounds (8, 10, 11, 50).
Toluene o-xylene monooxygenase (ToMO) from Pseudomo-
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nas sp. strain OX1 (4, 5, 15, 45) is a BMM that belongs to the
subfamily of four-component aromatic/alkene monooxygen-
ases (group 2 BMMs) (38). ToMO is endowed with a broad
spectrum of substrate specificity and, among others, is able to
oxidize o-, m-, and p-xylene, 2,3- and 3,4-dimethylphenol, tol-
uene, cresols, benzene, naphthalene, and styrene (4).
The ToMO complex, encoded by the tou gene cluster
(GenBank accession number AJ005663), is composed of six
polypeptides which are organized as four components (15).
ToMOF is the NADH oxidoreductase responsible for supply-
ing electrons to the diiron cluster housed into the active site of
the hydroxylase moiety. The electron transfer is mediated by
the Rieske protein ToMOC. The hydroxylase, named To-
MOH, consists of three polypeptides (B, E, A) organized in a
quaternary structure of the type (BEA)2; the active site is
housed in the subunit ToMOA (45). Finally, ToMOD has been
shown to be a regulatory protein, essential for efficient catalysis
and devoid of any metal or cofactor (15). The ToMO multi-
component system has been thoroughly investigated to identify
the molecular determinants responsible for its regioselective
hydroxylation of aromatic compounds (12–14, 51, 52). More-
over, a computational model was recently developed that
quantitatively predicts the effects of mutations into the active-
site pocket of ToMOA, thus allowing the rational design of
variants of the enzyme endowed with the desired regioselec-
tivity (37).
The main aim of the present work has been to investigate the
use of recombinant ToMO for the bioconversion of 2-phenyl-
ethanol, a cheap and commercially available substrate (22, 25),
to the high-added-value compound tyrosol.
Tyrosol (17) belongs to a class of natural phenolic antioxi-
dants commonly referred to as “nutraceuticals” (27) whose
role in the prevention of diseases such as cancer and cardio-
vascular diseases is emerging (16, 18, 19, 56). Moreover,
tyrosol is an excellent starting material for the microbial con-
version to hydroxytyrosol (1, 2, 6, 21), an ortho-diphenol abun-
dant in olive fruits and virgin olive oil, characterized by several
attractive properties such as antibacterial activity, scavenging
of free radicals, protection against oxidative DNA damage and
low-density lipoprotein oxidation, prevention of platelet aggre-
gation, and inhibition of 5- and 12-lipooxygenases (34, 39, 42,
43, 54).
Due to the inability of wt ToMO to produce tyrosol as the
sole isomer from the hydroxylation of 2-phenylethanol, we
developed a computational model to provide a molecular ex-
planation for this outcome. To validate our computational
model, several ToMO variants were designed and tested for
their ability to transform 2-phenylethanol into tyrosol. Our
results led to identification of residue F176 as a major steric
hindrance for the correct positioning of the reaction interme-
diate leading to tyrosol production. In fact, all the mutations at
position 176 allow ToMO to produce only tyrosol from 2-phe-
nylethanol. Moreover, we found that the combination of mu-
tations at position F176 with mutation E103G increases the
kcat values on 2-phenylethanol. Finally, among the E103G/
F176X variants, we found that mutants E103G/F176I and
E103G/F176T were the most efficient, allowing conversion of
about 50% of 2-phenylethanol into tyrosol in 2 h.
The results presented in this paper confirm that a fine-tuning
of ToMO regioselectivity can be achieved through a careful
alteration of the shape of the active-site pocket. Moreover, our
data indicate that this strategy can also help in designing
ToMO mutants that efficiently hydroxylate, with high regiose-
lectivity, any desired substituted benzene ring.
MATERIALS AND METHODS
Materials. Bacterial cultures, plasmid purifications, and transformations were
performed according to Sambrook et al (44). Escherichia coli strain JM109 was
from Novagen. Plasmid pTou was kindly supplied by Valeria Cafaro (Depart-
ment of Structural and Functional Biology, University Federico II, Naples, Italy).
The pGEM3Z expression vector, Wizard SV gel, and the PCR cleanup system
for the elution of DNA fragments from agarose gels were obtained from Pro-
mega. Enzymes and other reagents for DNA manipulation were from New
England BioLabs. The oligonucleotides were synthesized at MWG-Biotech
(Ebersberg, Germany). All other chemicals were from Sigma. Tyrosol was pur-
chased from Fluka. The expression and purification of recombinant catechol
2,3-dioxygenase (C2,3O) from Pseudomonas sp. OX1 are described elsewhere
(53).
ToMOA mutagenesis and construction of expression vectors. Plasmids for the
expression of ToMO complexes with mutated ToMOA subunits were obtained
by site-directed mutagenesis of plasmid pTou, coding for the complete tou gene
cluster, and prepared as previously described (13). Plasmid pTou was digested
with restriction enzymes MluI and SalI to extract a 1,200-bp internal fragment
from the touA open reading frame. This fragment lacked the first 36 bp and the
last 138 bp of the coding sequence and coded for amino acids 14 to 451 of the
ToMOA subunit. The MluI/SalI fragment was cloned into the pET22b() com-
mercial vector, and the resulting plasmid was designated pET22b()/touA. This
plasmid was used to obtain single mutants (F176I)-, (F176L)- (previously con-
structed as reported in reference 37), and (F176T)-ToMOA and double mutants
(E103G/F176A)-, (E103G/F176I)-, (E103G/F176L)-, (E103G/F176T)-, (E103G/
F176S)-, and (E103G/F176V)-ToMOA.
Mutations were introduced by a PCR-based methodology performed on the
parent pET-22b()/touA plasmid using a QuikChange site-directed mutagenesis
kit provided by Stratagene (La Jolla, CA), according to the manufacturer’s
protocol, and an MJ Research MiniCycler apparatus. PCR products were used to
transform by heat shock E. coli XL1-Blue competent cells (Stratagene, La Jolla,
CA), and cells were grown overnight on LB agar plates containing ampicillin
(100 g/ml). Three clones were picked from each plate, and their plasmids were
isolated with a Qiaprep Spin Miniprep kit (Qiagen) and used for sequencing. The
MluI/SalI fragments of the nine mutants were completely sequenced (MWG-
Biotech), digested with MluI and SalI, and cloned back into the pTou plasmid
previously digested with the same enzymes.
Identification of reaction products of ToMO-catalyzed hydroxylation of 2-phe-
nylethanol. Reaction products were identified by high-pressure liquid chroma-
tography (HPLC) and nuclear magnetic resonance (NMR). All the regioselec-
tivity studies were performed using substrate concentrations higher than the Km
values. Under these conditions, absolute yields of products were proportional to
kcat values. Reaction products were identified with an HPLC system equipped
with a Waters 1525 binary pump coupled to a Waters 2996 photodiode array
detector. Products were separated using an Ultrasphere C18 reverse-phase col-
umn (4.6 by 250 mm; pore size, 80 Å), and the absorbance of the eluate was
monitored at 254 nm for 2-phenylethanol and 276 nm for tyrosol. Separation was
carried out at a flow rate of 1 ml/min by using a two-solvent system consisting of
a 0.1% formic acid solution in water (solvent A) and a 0.1% formic acid solution
in methanol (solvent B). Compounds were separated using a 3-min isocratic
elution with 10% solvent B, followed by a 20-min linear gradient from 10 to 75%
solvent B and an isocratic 5-min step at 98% solvent B. The retention times of
2-phenylethanol and tyrosol under these conditions were 24.2 and 16.4 min,
respectively. The products were identified by comparing their HPLC retention
times and UV-visible spectra with those of standard solutions. The amount of
each product was determined by comparing the area of the peak with the areas
obtained using known concentrations of standards.
For a more detailed identification of the reaction products, cell-free superna-
tants obtained after transformation of 2-phenylethanol were extracted twice with
ethyl acetate added in a 1:2 ratio compared to the aqueous phase. The organic
phase was recovered and dried with a Savant apparatus, and the pellet was
dissolved in a solution of 10% methanol containing 0.1% formic acid. The
sample was further purified on a high-pressure liquid chromatograph under the
conditions described above; each peak was individually collected, concentrated,
and used in the NMR analysis.
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NMR analysis. Aliquots of the reaction mixture were withdrawn and fraction-
ated by HPLC (see above). Fractions collected at elution times of 16.4, 17.7, and
19.6 min were then extracted with ethyl acetate (3 ml, three times). The com-
bined organic layers were dried over sodium sulfate. The residues obtained were
directly used for NMR analysis in deuterated methanol.
1H NMR spectra were recorded at 600, 400, or 300 MHz, and 13C NMR
spectra were recorded at 75 MHz. 1H and 13C distortionless enhancement by
polarization transfer heteronuclear single-quantum correlation and 1H and 13C
heteronuclear multiple-quantum correlation (HMBC) experiments were run at
600 and 400 MHz, respectively, on instruments equipped with a 5 mm 1H/
broadband gradient probe with inverse geometry using standard pulse programs.
The HMBC experiments used a 100-ms long-range coupling delay. Chemical
shifts are reported in  values (ppm) downfield from tetramethylsilane.
Regioisomers were distinguished on the base of the spin-coupling pattern in
the aromatic region of the 1H NMR spectra (see Fig. S1 in the supplemental
material). Compound 1 showed only two signals featuring a doublet shape as a
consequence of the ortho-type coupling. On this basis, the direct attribution of
the symmetric para-substituted structure to compound 1, recognized as the
4-hydroxyphenylethanol, was allowed (see Fig. S1 in the supplemental material).
In the case of compounds 2 and 3 a more complex pattern in the aromatic
region of the 1H NMR spectra was present, suggesting a meta and an ortho
substitution of the aromatic rings (see Fig. S2 and S3 in the supplemental
material). The characterization of compounds 2 and 3 as 3-hydroxyphenylethanol
and 2-hydroxyphenylethanol, respectively, resulted from the ratios of shielded
and unshielded signals. Indeed, the ratio for compound 2 is 3 and is accounted
with the two H atoms in ortho and the one H atom in para to the OH group (see
Fig. S2 in the supplemental material). For compound 3, the ratio is 1, which is
coherent with the presence of only two shielded H atoms, with only one in ortho
and one in para to the OH group (see Fig. S3 in the supplemental material).
Whole-cell assays. The whole-cell assays were performed as previously de-
scribed (12) using E. coli JM109 cells transformed with the plasmid of interest.
Recombinant strains were routinely grown in Luria-Bertani medium (44) sup-
plemented with 100 g/ml ampicillin at 37°C to an optical density at 600 nm
(OD600) of 0.6. Expression of the recombinant protein was induced with 0.1
mM isopropyl--D-thiogalactopyranoside at 37°C in the presence of 0.2 mM
Fe(NH4)2(SO4)2. One hour after induction, cells were collected by centrifuga-
tion and suspended in M9 minimal medium containing 0.4% glucose, from here
on indicated as M9-G (12). The hydroxylase activity of cells was measured using
phenol as the substrate and monitoring the production of catechol in a contin-
uous coupled assay with recombinant C2,3O from Pseudomonas sp. OX1, which
cleaves the catechol ring and produces 2-hydroxymuconic semialdehyde. This can
be monitored spectrophotometrically at 375 nm. The specific activity of cells on
phenol was determined by their incubation at an OD600 of 0.1 to 0.5 in a quartz
cuvette in a final volume of 600 l of M9-G, 1 mM phenol, and saturating
amounts of C2,3O (3 U). The rate of formation of catechol (ε375  29,100 M	1
cm	1) was measured at 25°C.
Specific activity was expressed as the number of mU/OD600, with one milliunit
being defined as the amount of catalyst that oxidized 1 nmol of phenol per min
at 25°C.
The determination of apparent kinetic parameters using 2-phenylethanol as a
substrate was carried out by discontinuous assays with cells suspended in M9-G
in a final volume of 3.5 ml at an OD600 of 0.5. Reactions were started by the
addition to cell suspensions of various amounts of 2-phenylethanol dissolved in
methanol. The final methanol concentration in cell suspensions was always kept
below 5%.
At different times, a 1-ml aliquot was withdrawn and the reaction was stopped
by the addition of 100 l of 1 M HCl. Samples were centrifuged at 12,000 rpm
for 30 min at 4°C. Soluble fractions were stored at 	20°C until analysis. The
amount of tyrosol produced from hydroxylation of 2-phenylethanol was esti-
mated by the Folin-Ciocalteu reagent (47). The Folin-Ciocalteu reagent was used
under the following conditions: 700 l of soluble cell extract was added to 100 l
of M9-G and 50 l of Folin-Ciocalteu reagent (Sigma). Samples were incubated
for 10 min at 25°C. One hundred fifty microliters of saturated NaHCO3 was
added to each sample, which was then incubated for 2 h at 25°C. The A750 of each
sample was recorded. To calculate the rate of formation of tyrosol, an extinction
coefficient (ε750) of 26,000 M	1 cm	1 was used.
Determination of kinetic parameters. Kinetic parameters were calculated with
the program Prism (GraphPad Software). All the kinetic parameters were de-
termined using whole cells as previously described (12–14, 37).
Maximum rate of hydroxylation (Vmax) values for all mutants, using 2-phenyl-
ethanol as a substrate, were always normalized to the maximum rate measured
on phenol in a parallel assay. This was done for each sample of induced cells, and
for each mutant the experiment was repeated at least two or three times.
For each sample of induced cells, the level of expression of ToMO was
measured as described below and used to calculate the apparent kcat for phenol.
The amounts of ToMO complex were determined by densitometric scanning
of Coomassie blue-stained sodium dodecyl sulfate-polyacrylamide gels contain-
ing cell extracts. Different amounts of samples of lysed cells were run on a single
gel together with four different amounts of purified monooxygenases used as
standards.
All ToMO mutants showed expression levels comparable to the level for the
wild-type enzyme.
Modeling of substrates and intermediates into the active site of ToMOA.
Reaction intermediates were docked into the active site of ToMO by using the
Monte Carlo energy minimization strategy essentially as described previously
(37) but with a few modifications: (i) conformational energy calculations in-
cluded a hydration component calculated as described previously (29, 30) (the
hydration energy of Zn2 was arbitrarily assigned to iron ions), (ii) the inner
shell included 30 ToMO residues surrounding the active-site cavity, and (iii)
complexes with total energies of up to 4 kcal/mol higher than that of the lowest-
energy complex were stored for the analysis of energy contributions. 2-Phenyl-
ethanol was docked as described above for reaction intermediates but with the
following modifications: (i) no hydration component was assigned to the iron
ions, and (ii) the inner shell and the outer shell were enlarged to 51 and 181
ToMO residues, respectively. The docking of phenylethanol was performed in
three steps: (i) the ToMO-phenylethanol complexes were minimized with phe-
nylethanol locked to an orientation similar to that of the reaction intermediate
for the hydroxylation at the para position using the atom-atom distance con-
straints; (ii) the centroid and grid functions were used to generate eight orien-
tations of phenylethanol inside the active-site cavity; and (iii) the eight ToMO-
phenylethanol complexes were minimized without constraining the orientation of
phenylethanol, except that the oxygen-iron distances were constrained to values
higher than 4 Å to avoid the accumulation of complexes with the oxygen atom of
phenylethanol at a bridging position between the iron ions.
The Protein Data Bank files for the initial manually generated complexes and
the ZMM instruction files containing the lists of mobile residues, constraints, and
parameters used during calculations are available upon request.
Other methods. Polyacrylamide gel electrophoresis was carried out using stan-
dard techniques (28, 44). Tris-glycine gels were run as 18% gels under denaturing
conditions. Protein concentrations were determined colorimetrically with the
Bradford reagent (9) from Sigma, using 1 to 10 g bovine serum albumin as a
standard.
RESULTS AND DISCUSSION
ToMO-catalyzed hydroxylation of 2-phenylethanol. On the
basis of the similarity between 2-phenylethanol and the natural
aromatic substrates of ToMO, we investigated the possibility of
using this multicomponent enzyme to hydroxylate 2-phenyl-
ethanol to form tyrosol.
Cells of E. coli strain JM109 transformed with plasmid
pBZ1260 expressing the ToMO gene cluster were grown in LB
medium, and the expression of the recombinant multicompo-
nent system was induced as described in Materials and Meth-
ods. After 1 h of induction, cells were collected by centrifuga-
tion, resuspended in M9-G at a final concentration of 6 OD600
units, and incubated with 5 mM 2-phenylethanol. After incu-
bation for different times (0.5, 2, 4, and 14 h) under constant
shaking, 1-ml samples were withdrawn, cells were collected by
centrifugation, and the supernatants were analyzed by HPLC
as described in Materials and Methods. HPLC chromatograms
showed that ToMO was able to hydroxylate 2-phenylethanol.
Three different peaks were evident from the chromatogram
(Fig. 1); the peaks were manually collected and identified by
NMR (see Materials and Methods and Fig. S1 to S3 in the
supplemental material). The analysis showed that the com-
pound eluting in peak 1 (at 16.4 min) was 4-hydroxyphenyl-
ethanol (tyrosol; from here on indicated p-tyrosol [10]), the
compound eluting in peak 2 (at 17.7 min) was 3-hydroxyphe-
nylethanol (from here on indicated m-tyrosol [10]), and the
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compound eluting in peak 3 (at 19.6 min) was 2-hydroxyphe-
nylethanol (from here on indicated o-tyrosol [10]). m-Tyrosol
accounted for ca. 90% of the total yield of product, whereas
p-tyrosol and o-tyrosol accounted only for ca. 5% each. It
should be noted that the preferential regioselectivity of the
ToMO-catalyzed reaction toward the meta position of 2-phe-
nylethanol has recently been reported (10). Hence, it was ev-
ident that 2-phenylethanol can be hydroxylated by ToMO
mainly to m-tyrosol, whereas the desired product, p-tyrosol,
was produced in very low yields. Kinetic parameters of the
hydroxylation reaction using 2-phenylethanol as a substrate
were calculated in discontinuous assays using whole recombi-
nant cells of E. coli strain JM109, as described in the Materials
and Methods section. The Km using this substrate is 211 
 22
M, and the kcat value is 0.054 
 0.016 s
	1.
Docking of 2-phenylethanol into active site of ToMOA. A
computational strategy, based on a Monte Carlo approach, was
recently developed that quantitatively predicts the effects of
mutations in the active-site pocket of the hydroxylase moiety of
ToMO on the regioselectivity shown by this enzyme on phys-
iological substrates (37). Our aim has been to broaden this
computational strategy and to use its predictions to tune
ToMO regioselectivity and catalytic efficiency also on non-
physiological substrates.
Briefly, the computational strategy is based on a simple
kinetic model which predicts the regioselectivity on aromatic
substrates of ToMO and its mutants by calculating the relative
stability of the orientations of different transition states gener-
ated by different enzyme-substrate complexes (37) (Fig. 2A
and B). In this model the substrate binds to the active site in
different orientations, generating productive and unproductive
enzyme-substrate complexes (Fig. 2B). The three possible pro-
ductive complexes are in equilibrium both with the unproduc-
tive complexes and with the three transition states, leading to
the o-, m-, and p-substituted phenols (oC, mC, and pC, respec-
tively, in Fig. 2B). According to this kinetic model, the regio-
selectivity of the enzyme depends only on the relative stability
of the three different transition states. This assumption allows
us to predict the relative abundance of the products by docking
the putative high-energy intermediates (arenium ions in Fig.
2A) into the active site (37).
However, the kinetic model shown in Fig. 2B also suggests
that the catalytic efficiency and, in particular, the apparent kcat
value of a ToMO mutant should depend both on the absolute
stability of the transition state(s) and on the relative abun-
dance of the productive and unproductive enzyme-substrate
complexes (Fig. 2B). Thus, the model will predict an efficient
ToMO-catalyzed hydroxylation of a substituted benzene like
2-phenylethanol to a desired substituted phenol, e.g., p-tyrosol,
(i) if the high-energy intermediate corresponding to the de-
sired phenol product fits the active site well and fits better than
any other possible high-energy intermediate and (ii) if the
ToMO-substrate complex in which the substrate is produc-
tively oriented for catalysis is the most abundant one.
We have previously suggested (37) that the stability of the
transition state is the sum of two contributions: (i) a noncova-
lent contribution (noncovalent binding energy [ncBE]) de-
pending on noncovalent interactions between the high-energy
intermediate and the active-site pocket, which can be calcu-
lated by molecular mechanics techniques like Monte Carlo
docking (37), and (ii) a covalent contribution depending on the
bonds between the oxygen atom of the high-energy intermedi-
ate and the iron ions of the cluster, i.e., on the geometrical
parameters of the diiron clusters-arenium ion complex (Fig.
2A and C), which can be calculated only by a complex quan-
tum-mechanical treatment of the transition state. However,
the Monte Carlo docking of benzene, toluene, and o-xylene
arenium intermediates showed that the arenium ring of all the
intermediates deriving from these physiological substrates
adopts very similar orientations within the active-site pocket of
FIG. 1. Regioselectivity of the ToMO-catalyzed reaction using 2-phenylethanol as a substrate. An HPLC chromatogram was monitored at a 
of 276 nm and showed the presence of three products (compounds 1, 2, and 3) corresponding to p-tyrosol, m-tyrosol, and o-tyrosol, respectively.
AU, absorbance units. (Inset) Relative percentages of each product.
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wild-type ToMO (37). Therefore, these Monte Carlo energy-
minimized complexes can be considered a reliable model of
the optimal transition state for the aromatic hydroxylation
reaction and can be used as a reference structure to analyze
interactions between the ToMO active site and the high-energy
intermediates deriving from nonnatural substrates of this en-
zyme (37).
In this study we used as a reference structure the Monte
Carlo energy-minimized complex between wild-type ToMO
and the high-energy intermediate for the conversion of toluene
to p-cresol, since this reaction is similar to the desired hydroxy-
lation of 2-phenylethanol to p-tyrosol.
Table 1 shows that a correlation exists between the kcat
values on toluene of some ToMO mutants (37) and the pre-
dicted orientation of the arenium intermediates for the tolu-
ene/p-cresol reaction with respect to that of our reference
structure. Two geometrical parameters defining the orienta-
tion of the arenium ring with respect to the diiron cluster were
used for the comparison: (i) the distance between the C-4 atom
of the mutant-generated complex and the C-4 atom of the
reference complex, and (ii) , a parameter that measures the
angle deviation of the plane of the arenium ring in a ToMO
mutant-intermediate complex with respect to the plane of the
arenium ring in the reference structure. , whose value in the
reference structure is 103.6°, is the torsion angle Fe-2–O–C-4–
C-3 (Fig. 2C). It should be noted that the choice of the C-4
atom was made on the basis of the critical importance of this
position of the substrate, which is responsible for accepting the
oxygen atom from the diiron cluster during the hydroxylation
reaction (Fig. 2A).
It is evident from the data in Table 1 and Fig. S4 in the
supplemental material that ToMO mutants characterized by
C-4–C-4 distances less than 0.15 Å and  values of about
	10° to 5° show high kcat values (similar to or greater than
FIG. 2. Kinetic model depicting the regioselectivity of ToMO-catalyzed reactions. (A) Hypothetical enzyme-substrate intermediates during the
hydroxylation of an aromatic substrate in the active site of ToMOA; (B) distribution and kinetic constants of productive and nonproductive
enzyme-transition state complexes; (C) modeling of the 4-hydroxyphenylethanol intermediate in the active site of ToMOA.
TABLE 1. Geometric parameters of the complexes between ToMO
and ToMO mutants and the arenium intermediate for
the toluene/p-cresol reaction
Complex C-4–C-4 (Å)  (°) kcat (s	1)a
(L100, G103)/S4Mb 0.05 	9.0 0.67
L100/S4M 0.06 	1.2 0.56
wt/S4M 0 0 0.43
G103/S4M 0.04 	6.8 0.42
(I180, G103)/S4M 0.04 	6.5 0.34
L176/S4M 0.11 	2.1 0.32
I176/S4M 0.07 2.0 0.28
I103/S4M 0.15 3.8 0.22
(V103, V100)/S4M 0.2 2.5 0.097
A100/S4M 0.05 12.0 0.03
I103/S4M 0.23 15.0 0.030
V107/S4M 0.40 	7.1 0.024
I107/S4M 0.49 	9.2 0.0009
a kcat values are from reference 37.
b S4M, toluene/p-cresol.
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those for wild-type ToMO), whereas ToMO mutants charac-
terized by C-4–C-4 distances higher than 0.2 Å and/or 
values 5° show kcat values significantly lower than those
measured for the wild-type enzyme.
Hence, we docked into the active site of wild-type ToMO the
three high-energy intermediates for the hydroxylation of
2-phenylethanol to o-, m-, and p-tyrosol (these intermediates
are indicated 2PE, 3PE, and 4PE, respectively, from here on).
As shown in Table 2, the geometries of all the high-energy
intermediates showed considerable deviations from the ideal
geometry, in agreement with the fact that wild-type ToMO is a
bad catalyst for the 2-phenylethanol hydroxylation (kcat value,
0.054 
 0.016 s	1) compared to the natural substrate toluene
(kcat value, 0.43 s
	1). The highest deviations from the ideal
orientation were observed in the case of the intermediates 2PE
and 4PE, and the lowest was observed for the intermediate
3PE, in agreement with the observation that wild-type ToMO
produces ca. 90% m-tyrosol.
A close inspection of the model of the ToMO-4PE complex
(Fig. 3A), i.e., the analog of the intermediate leading from
2-phenylethanol to the desired substituted phenol, e.g., p-
tyrosol, showed that van der Waals contacts between the side
chain of Phe-176 and the hydroxyethyl moiety of 4PE that are
too close prevent the positioning of the arenium ring of this
intermediate in an orientation similar to that of the reference
structure, thus providing a geometrical explanation for the low
production of p-tyrosol by wild-type ToMO (Fig. 3A and B).
We repeated the same analysis on six ToMO mutants with
smaller residues at position 176 (Ile, Leu, Val, Thr, Ser, and
Ala). In this case, the docking procedure was carried out only
with the high-energy intermediates 3PE and 4PE, because a
preliminary analysis revealed that mutations at position 176
did not significantly change the C-4–C-4, , and ncBE values
for 2PE with respect to that measured for wt ToMO (data not
shown).
The data in Table 2 indicate that the geometrical parameters
of most of these mutants show a better similarity of their
complexes with the reference structure only in the case of the
arenium ring of 4PE, the intermediate leading to p-tyrosol. The
data show that for all mutations at position 176, the orientation
of the 4PE intermediate is more similar to that of the reference
model than that of wt ToMO: the C-4–C-4 distances are be-
tween 0.13 and 0.20 Å and the  values are between 	9° and
10°. However, these values are out of the limits defined from
the data in Table 1. Moreover, a careful inspection of these
complexes revealed that the side chain of Glu-103, which, in wt
ToMO, is closely packed to the Phe-176 side chain, could limit
the conformational freedom of the side chain of residues mod-
eled at position 176. Therefore, we also modeled six double
mutants in which all the mutations at position 176 were cou-
pled with mutation E103G, which could, in principle, remove
the hindrance of the bulky side chain at position 103. Data in
Table 2 show that for all the double mutants, with the excep-
tion of ToMO mutant (E103G, F176L), the C-4–C-4 distances
are less than 0.1 Å and  values are less than 0°, i.e., within
the limits defined from the data in Table 1 for high-kcat mu-
tants, only when docking the arenium ring of 4PE. It is also
worth noting that as the orientation of the intermediate 4PE
becomes more similar to that of the reference model complex,
the ncBE of the intermediate becomes more negative, thus
indicating a better fit between the 4PE intermediate and the
active-site pocket.
Thus, on the basis of our assumption, i.e., that a correlation
exists between the kcat values and the predicted orientation of
the arenium rings compared to that of the reference structure,
we can hypothesize that all mutations at position 176, both
alone and in combination with mutation E103G, selectively
improve the binding of the intermediate 4PE. As a conse-
quence, these mutants should exclusively produce p-tyrosol.
However, according to our kinetic model, a good positioning
of the arenium intermediate, although essential, is not a suf-
ficient condition for an efficient catalysis, given that mutations
TABLE 2. Geometric parameters and ncBEs of the complexes between ToMO and ToMO mutants and the arenium intermediates
for the 4PE, 3PE, and 2PE reactions
Amino acid
Arenium ion
4PE 3PE 2PE
Position
103
Position
176 C-4–C-4 (Å)  (°)
ncBE
(kcal mol	1) C-4–C-4 (Å)  (°)
ncBE
(kcal mol	1) C-4–C-4 (Å)  (°)
ncBE
(kcal mol	1)
Glua Phea 0.30 41 	7.8 0.23 22 	5.7 0.37 44 	5.0
Glyb Pheb 0.28 41 	7.5 0.23 24 	5.6 —c — —
Glu Ala 0.20 	10 	11.0 0.20 17 	9.5 — — —
Glu Ile 0.13 	4 	11.0 0.31 35 	8.9 — — —
Glu Leu 0.17 	6 	11.1 0.35 37 	7.5 — — —
Glu Ser 0.15 9 	10.9 0.22 20 	9.3 — — —
Glu Thr 0.20 	10 	11.0 0.22 17 	9.4 — — —
Glu Val 0.14 	6 	11.0 0.21 15 	9.5 — — —
Gly Ala 0.08 	14 	11.8 0.22 22 	9.0 — — —
Gly Ile 0.08 	10 	11.7 0.20 16 	8.5 — — —
Gly Leu 0.14 	5 	10.8 0.30 38 	6.3 — — —
Gly Ser 0.06 	11 	11.5 0.22 18 	8.9 — — —
Gly Thr 0.05 	11 	11.5 0.20 30 	8.9 — — —
Gly Val 0.05 	7 	11.5 0.18 29 	8.8 — — —
a Wild-type ToMOA.
b (E103G)-ToMOA.
c —, not determined.
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which stabilize unproductive orientations of the substrate will
reduce the apparent kcat value. Therefore, even if all the dou-
ble mutants bind the 4PE intermediate in a correct orientation
and with similar noncovalent binding energies, different kcat
values could be obtained.
In order to predict which double mutant(s) is the best cat-
alyst(s) for the production of p-tyrosol, it is necessary to define
a strategy to predict the ratio between the abundance of pro-
ductive and nonproductive enzyme-substrate complexes.
Monte Carlo docking of the substrate 2-phenylethanol pro-
vides a panel of possible orientations of the substrate in the
active site of the double mutants, whereas comparison of the
orientations of 2-phenylethanol in the complexes and the ref-
erence structure, i.e., the complex between wild-type ToMO
and the arenium intermediate for the conversion of toluene to
p-cresol, helps to discriminate between productive and non-
productive enzyme-substrate complexes. Thus, we docked
2-phenylethanol into the active site of the double mutants; the
total energies of the complexes were calculated and used to
estimate their relative abundance at equilibrium. Finally, we
compared the orientations of the substrate in these complexes
with the orientation of the arenium intermediate in the refer-
ence structure. Figure 4 shows the abundance of the ToMO-
phenylethanol complexes as a function of the distance between
the C-4 atom of 2-phenylethanol and the C-4 atom of the
reference structure (x axis) and of the root mean square devi-
ation (RMSD) between the ring of phenylethanol and the
arenium ring of the reference structure (y axis). It should be
noted that as 2-phenylethanol is not covalently bound to the
diiron cluster, in this case, the Fe-2–O–C-4–C-3 torsion angles,
, are meaningless.
Data in Fig. 4 show that the double mutants dock 2-phenyl-
ethanol in slightly different orientations. (E103G, F176T)- and
(E103G, F176I)-ToMO show high percentages of complexes
with very short C-4–C-4 distances and RMSDs, respectively.
This means that in this case 2-phenylethanol adopts in the
active site orientations very similar to the orientation of the
arenium ion of the reference structure, thus suggesting that
the active sites of these mutants can properly orient the sub-
strate for catalysis. On the contrary, only complexes with both
relatively long C-4–C-4 distances and RMSDs are predicted
for a mutant like (E103G, F176A)-ToMO, suggesting that in
this mutant a larger rearrangement is necessary to switch from
the enzyme-substrate complex to the transition state (the en-
zyme-arenium ion complex). The remaining three double mu-
tants show an intermediate behavior. On the basis of our data,
FIG. 3. Structures of the complexes between wt ToMO or ToMO
mutants and the arenium intermediates for the reactions 4PE (A), 3PE
(B), and toluene/p-cresol (S4M) (A and B). Carbon atoms are shown
in green (S4M/ToMO), yellow (4PE/ToMO and 3PE/ToMO), and
magenta [4PE/(E103G, F176I)-ToMO and 3PE/(E103G, F176I)-
ToMO]; oxygen atoms are shown in red, and nitrogen atoms are shown
in blue. Hydrogen atoms are not shown.
FIG. 4. Calculated relative abundance (in percent) of the ToMO–
2-phenylethanol complexes as a function of the distance between the
C-4 atom of the 2-phenylethanol and the C-4 atom of the reference
structure and of the RMSD between the ring of 2-phenylethanol and
the ring of the reference structure. Red circles, (E103G, F176A)-
ToMO; gray circles, (E103G, F176I)-ToMO; cyan circles, (E103G,
F176L)-ToMO; blue circles, (E103G, F176S)-ToMO; green circles,
(E103G, F176T)-ToMO; yellow circles, (E103G, F176V)-ToMO.
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we can predict the following order of kcat values: (E103G,
F176T)- and (E103G, F176I)-ToMO  (E103G, F176L)-,
(E103G, F176V)-, and (E103G, F176S)-ToMO  (E103G,
F176A)-ToMO.
To validate our hypothesis, we prepared and characterized
mutants with single mutations of ToMOA, i.e., F176I, F176L,
and F176T, as well as mutants with double mutations, E103G-
F176(I, L, T, A, S, V), to verify whether these changes would
affect the catalytic efficiency of the enzyme on 2-phenylethanol
according to our predictions.
Identification of reaction products and determination of
kinetic parameters of ToMO mutant-catalyzed hydroxylation
of 2-phenylethanol. Enzymatic assays on recombinant whole
cells of E. coli strain JM109 expressing ToMOA mutants and
using 2-phenylethanol as substrate were carried out as de-
scribed in the Materials and Methods section. Reaction prod-
ucts were identified by HPLC and NMR. Our results (Fig. 5)
clearly indicate that substitution of residue F176 is essential to
obtain almost exclusively p-tyrosol from 2-phenylethanol. For
all mutants with a mutation at position 176, no detectable
o-tyrosol was observed and m-tyrosol yields were less than 2%.
Also, double mutants produced only p-tyrosol, whereas
ToMOA variant E103G shows the same regiospecificity as the
wild-type enzyme on 2-phenylethanol (data not shown). The
analysis of the kinetic parameters (Table 3) indicates that vari-
ants bearing E103G/F176X mutations have higher kcat values
on 2-phenylethanol than the corresponding variants with single
mutations. Therefore, confirming our hypothesis, it seems that
reduction of steric hindrance at position 103 (13, 37, 45) acts in
a synergistic manner with mutations at position 176. Global
reduction of steric hindrance inside the active site likely allows
for a better fitting of 2-phenylethanol, resulting in an increase
of the kcat value. It should be noted, however, that the strategy
of widening the active site fails to be effective when the data
obtained for mutant E103G/F176A are analyzed. In this case,
in fact, an excessive broadening of the active site leads to a
drastic decrease in the catalytic efficiency of the enzyme, likely
due to a degree of freedom of 2-phenylethanol inside the
active site of this mutant that is too high.
The higher kcat value measured on 2-phenylethanol is ob-
tained with variant E103G/F176T. The Monte Carlo-mini-
mized models show that in this double mutant theOOH group
of threonine forms an H bond with the backbone oxygen atom
of Ala-172, whereas the methyl group points toward the active-
site cavity and makes van der Waals interactions with the
hydroxyethyl group of both 2-phenylethanol and the 4PE in-
termediate (see Figure S5A and B in the supplemental mate-
rial). Thus, the model suggests that the active site of mutant
E103G/F176T allows for the appropriate orientation of both
the substrate and the intermediate. In this mutant, however,
van der Waals contacts between the methyl group of the
threonine residue and the hydroxyl group of 2-phenylethanol
involve a partial desolvation of the hydroxyl group of the sub-
FIG. 5. Regioselectivity of ToMO/F176T-catalyzed reaction using 2-phenylethanol as a substrate (solid line). An HPLC chromatogram
monitored at a  of 276 nm shows the presence of a single product corresponding to p-tyrosol. The dashed-line trace is the HPLC profile monitored
under the same experimental conditions using wt ToMO. Results are similar for both the F176X and E103G/F176X mutants. AU, absorbance
units.
TABLE 3. Apparent Km and kcat values of ToMO and ToMO
mutants using 2-phenylethanol as substrate
Mutant Km (M) kcat (S	1)
wt 211 (
22) 5.4 (
1.6)  10	2
F176I 392 (
28) 2.8 (
0.1)  10	2
F176L 276 (
52) 3.8 (
0.5)  10	2
F176T 662 (
46) 14.0 (
0.5)  10	2
E103G/F176A 404 (
25) 6.0 (
0.1)  10	2
E103G/F176I 759 (
160) 47.0 (
4.0)  10	2
E103G/F176L 362 (
44) 18.0 (
0.7)  10	2
E103G/F176T 1,045 (
66) 71.0 (
1.9)  10	2
E103G/F176S 557 (
42) 14.5 (
0.5)  10	2
E103G/F176V 435 (
52) 14.9 (
0.6)  10	2
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strate (see Fig. S5B in the supplemental material), thus deter-
mining a decrease of the apparent affinity for the substrate
(i.e., an increase of the Km value; Table 3).
Thus, our experimental results are in good agreement with
the computational model. First, the model identified residue
F176 as the major constraint for the productive orientation of
the 4PE reactive intermediate. Moreover, our model correctly
predicts an increase of the kcat value on 2-phenylethanol when
mutation F176X, responsible for the regioselectivity of the
hydroxylation reaction on this substrate, is combined with mu-
tation E103G.
This can be noticed by comparing the data in Fig. 4 and the
kcat values in Table 3. The two double mutants with the highest
kcat values, (E103G, F176T)- and (E103G, F176I)-ToMO, in
fact show high percentages of complexes with very short C-4–
C-4 distances and RMSDs, respectively. Mutant (E103G,
F176A)-ToMO, the one with the lowest kcat value among the
double mutants, is instead predicted to yield only complexes
with long C-4–C-4 distances and high RMSDs. The other three
double mutants show an intermediate behavior for C-4–C-4
distances and RMSDs and also show intermediate kcat values.
We can affirm that the docking procedure that we have devel-
oped allows prediction of the relative kcat values of ToMO
mutants on the nonphysiological substrate 2-phenylethanol.
Finally, with the aim of investigating a future industrial ap-
plication of ToMO mutants for the bioconversion of 2-phe-
nylethanol to p-tyrosol, we calculated the yield of p-tyrosol
produced by the most effective catalysts, E103G/F176I and
E103G/F176T (Table 3). The yield of p-tyrosol produced in a
minimal medium by recombinant whole cells was evaluated in
batch experiments. E. coli strain JM109 cells harboring the
plasmid coding for either the E103G/F176I or the E103G/
F176T mutant were grown and induced as described in Mate-
rials and Methods. After induction, cells were harvested and
suspended in M9-G medium containing 2 mM 2-phenylethanol
at an OD600 of 1. Cells were then incubated at 30°C, under
constant shaking at 200 rpm. At different times a 1-ml sample
was withdrawn and centrifuged at 12,000 rpm at 4°C for 10
min, and an aliquot of the cell-free supernatant was analyzed
by HPLC. The amount of either 2-phenylethanol or p-tyrosol
was determined by comparing the area of each peak with the
area obtained using known concentrations of standards. p-
Tyrosol was the only isomer produced (within the limits of our
assay procedure) with mutants E103G/F176I and E103G/
F176T. After 2 h of incubation, the yields of transformation
obtained from 2-phenylethanol were 50.2 
 0.2% for E103G/
F176I and 56.3 
 2.4% for E103G/F176T.
Conclusions. Both directed evolution and rational design
approaches have been successfully used in numerous studies
probing multicomponent monooxygenase-catalyzed reactions
(10, 11, 13, 14, 24, 37, 49, 52). These studies clearly show that
these monooxygenases may be considered an archive of pow-
erful and versatile enzymes which can be used to create new
catalysts useful for diverse purposes, such as bioremediation of
harmful compounds and industrial biosynthesis, among others.
We have previously shown that a fine-tuning of the regiose-
lectivity of the BMM ToMO from Pseudomonas sp. OX1 on
natural substrates can be achieved through careful alteration
of the shape of the active site and that the effects of the
mutations on regioselectivity can be quantitatively predicted a
priori (13, 37). The computational model described in this
paper and tested by its application to the synthesis of p-tyrosol
from 2-phenylethanol, a nonnatural substrate of ToMO, im-
proves the model previously presented for this enzyme (37).
Our experimental data validate the computational model pre-
sented in this work, showing that mutation of residue F176
allows ToMO to produce exclusively p-tyrosol from 2-phenyle-
thanol and that mutation E103G increases the efficiency of
catalysis of the enzyme on this substrate.
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